成人免费xx,国产又黄又湿又刺激不卡网站,成人性视频app菠萝网站,色天天天天

Home Cart Sign in  
Chemical Structure| 111025-46-8 Chemical Structure| 111025-46-8
Chemical Structure| 111025-46-8

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

{[proInfo.proName]}

CAS No.: 111025-46-8

,{[proInfo.pro_purity]}

Pioglitazone (U 72107) is an orally active and selective PPARγ (peroxisome proliferator-activated receptor) agonist, binding with high affinity to the PPARγ ligand-binding domain with EC50 values of 0.93 μM and 0.99 μM for human and mouse PPARγ, respectively. It is used in diabetes research.

Synonyms: U 72107; AD-4833

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support Online Technical Q&A
Product Citations

Alternative Products

Product Details of Pioglitazone

CAS No. :111025-46-8
Formula : C19H20N2O3S
M.W : 356.44
SMILES Code : O=C(N1)SC(CC2=CC=C(OCCC3=NC=C(CC)C=C3)C=C2)C1=O
Synonyms :
U 72107; AD-4833
MDL No. :MFCD00865504
InChI Key :HYAFETHFCAUJAY-UHFFFAOYSA-N
Pubchem ID :4829

Safety of Pioglitazone

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H302-H312-H332
Precautionary Statements:P261-P264-P270-P271-P280-P301+P312-P302+P352-P304+P340-P330-P363-P501

Isoform Comparison

Biological Activity

Clinical Trial:

NCT Number Conditions Phases Recruitment Completion Date Locations
NCT00861341 - Completed - -
NCT00719381 Cystic Fibrosis PHASE1 COMPLETED 2025-06-09 University of Southern Califor... More >>nia, Los Angeles, California, 90089, United States Less <<
NCT02733679 Ataxia-Telangiectasia Phase 4 Completed - United Kingdom ... More >> Ninewells Hospital Dundee, Angus, United Kingdom, DD19SY Less <<
NCT00671515 Depressive Disorder, Major|Met... More >>abolic Syndrome X Less << PHASE2 COMPLETED 2025-11-11 University Hospitals Cleveland... More >> Medical Center - Mood Disorders Program, Cleveland, Ohio, 44106, United States Less <<
NCT00671515 Depressive Disorder, Major|Met... More >>abolic Syndrome X Less << PHASE2 COMPLETED 2025-11-11 University Hospitals Cleveland... More >> Medical Center - Mood Disorders Program, Cleveland, Ohio, 44106, United States Less <<
NCT00494559 Diabetes Mellitus ... More >> Coronary Artery Stenosis Less << Phase 4 Completed - Korea, Republic of ... More >> Korea University Anam Hospital Seoul, Korea, Republic of, 136-705 Less <<
NCT01109030 Major Depressive Disorder Phase 2 Phase 3 Completed - Iran, Islamic Republic of ... More >> Department of psychiatry, Roozbeh psychiatric hospital, Tehran University of medical sciences Tehran, Iran, Islamic Republic of, 14479 Less <<
NCT01184144 Endometriosis PHASE2|PHASE3 WITHDRAWN 2025-05-12 -
NCT00220961 Impaired Glucose Tolerance ... More >> Type 2 Diabetes Less << Phase 3 Completed - United States, Arizona ... More >> Carl T. Hayden VA Medical Center Phoenix, Arizona, United States, 85012 United States, California USC-Keck School of Medicine Los Angeles, California, United States, 90033 University of California San Diego-San Diego VA Medical Center San Diego, California, United States, 92161 United States, District of Columbia Georgetown University Washington, District of Columbia, United States, 20007 United States, Louisiana Pennington Biomedical Research Center Baton Rouge, Louisiana, United States, 70808 United States, New York SUNY Health Science Center Brooklyn, New York, United States, 11203 United States, Tennessee University of Tennessee Memphis, Tennessee, United States, 38163 United States, Texas Texas Diabetes Institute San Antonio, Texas, United States, 78207 Less <<
NCT01963663 Type 2 Diabetes Mellitus Not Applicable Completed - Iran, Islamic Republic of ... More >> Diabetes Clinic, Vali-Asr Hospital, Tehran University of Medical Sciences Tehran, Iran, Islamic Republic of, 13145-784 Less <<
NCT00220961 - Completed - -
NCT01124656 Diabetes Mellitus, Type 2 Phase 3 Terminated(Formulation issues.... More >>) Less << - -
NCT00681733 Metabolic Parameters and Liver... More >> Histology Less << Not Applicable Unknown December 2008 India ... More >> Dr. Barjesh Chander Sharma Recruiting New Delhi, India, 110001 Contact: Barjesh Ch Sharma, MD, DM ?? 91-011-2323-4242 ext 5203 ?? drbcsharma@hotmail.com ?? Principal Investigator: Barjesh Ch Sharma, MD, DM Less <<
NCT02852486 Leukemia, Chronic Myeloid Phase 2 Recruiting June 2022 Brazil ... More >> Centro de Hematologia e Hemoterapia - Universidade Estadual de Campinas Recruiting Campinas, SP, Brazil, 13083-868 Contact: Katia B Pagnano, MD ?? 55-19-35218740 ?? kborgia@unicamp.br ?? Contact: Márcia T Delamain, MD ?? 55-19-35218740 ?? marciatd@unicamp.br ?? Principal Investigator: Katia B Pagnano, MD ?? ?? ?? Sub-Investigator: Márcia T Delamain, MD ?? ?? ?? Sub-Investigator: Gislaine O Duarte, MD ?? ?? ?? Sub-Investigator: Erich V De Paula, MD ?? ?? ?? Sub-Investigator: Carmino A De Souza, MD Less <<
NCT01205282 Autism Spectrum Disorders Phase 2 Completed - Canada, Ontario ... More >> Holland Bloorview Kids Rehabilitation Hospital Toronto, Ontario, Canada, M4G 1R8 Less <<
NCT00994175 Severe, Refractory Asthma ... More >> Airway Inflammation Airflow Obstruction Less << Phase 2 Completed - United States, Maryland ... More >> National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States, 20892 United States, Virginia INOVA Fairfax Hospital Falls Church, Virginia, United States, 22042 Less <<
NCT00174993 Diabetes Mellitus Phase 3 Completed - -
NCT00994175 - Completed - -
NCT01873001 Healthy Volunteers Phase 1 Completed - Belgium ... More >> Merksem, Belgium Less <<
NCT03117517 Polycystic Ovarian Syndrome Early Phase 1 Completed - Pakistan ... More >> Mardan Medical Complex Mardan, Khyber Pukhtunkhwah, Pakistan, 25000 Less <<
NCT00951379 Oral Leukoplakia Phase 2 Terminated(Due to slow accrual... More >>.) Less << - United States, Alabama ... More >> University of Alabama at Birmingham Birmingham, Alabama, United States, 35294 United States, Iowa University of Iowa Hospitals and Clinics Iowa City, Iowa, United States, 52242 United States, Massachusetts Brigham and Women's Hospital Boston, Massachusetts, United States, 02115 United States, Minnesota Masonic Cancer Center, University of Minnesota Minneapolis, Minnesota, United States, 55455 United States, New York Roswell Park Cancer Institute Buffalo, New York, United States, 14263 Columbia University Medical Center New York, New York, United States, 10032 Memorial Sloan-Kettering Cancer Center New York, New York, United States, 10065 Weill Medical College of Cornell University New York, New York, United States, 10065 United States, South Carolina Medical University of South Carolina Charleston, South Carolina, United States, 29425 United States, Texas MD Anderson Cancer Center Houston, Texas, United States, 77030 United States, Wisconsin University of Wisconsin Hospital and Clinics Madison, Wisconsin, United States, 53792 Canada, British Columbia BC Cancer Agency (Vancouver Cancer Centre) Vancouver, British Columbia, Canada, V5Z 4E6 Italy European Institute of Oncology Milano, Italy, 20141 Less <<
NCT01331967 Diabetic Stable Angina|Diabeti... More >>c Unstable Angina Less << PHASE4 COMPLETED 2025-08-13 Korea University Anam Hospital... More >>, Seoul, 136705, Korea, Republic of Less <<
NCT00951379 - Terminated(Due to slow accrual... More >>.) Less << - -
NCT01799850 Diabetes Type 2 Phase 4 Completed - United States, Tennessee ... More >> ETSU Quillen College of Medicine Johnson City, Tennessee, United States, 37614 Less <<
NCT00639457 HIV Infections ... More >> Type 2 Diabetes Obesity HIV AIDS Cardiovascular Disease Lipodystrophy Less << Not Applicable Completed - United States, Missouri ... More >> Washington University School of Medicine St. Louis, Missouri, United States, 63110 Less <<
NCT00639457 - Completed - -
NCT01588470 Type 2 Diabetes ... More >> Coronary Heart Disease Less << Phase 4 Completed - -
NCT01588470 - Completed - -
NCT00099021 - Completed - -
NCT00099021 Head and Neck Cancer ... More >> Oral Leukoplakia Less << Phase 2 Completed - United States, Minnesota ... More >> University of Minnesota Medical Center-Fairview Minneapolis, Minnesota, United States, 55455 Less <<
NCT01322308 Systemic Lupus Erythematosus Phase 4 Completed - -
NCT02426294 Type 2 Diabetes Mellitus Phase 4 Unknown May 2016 Korea, Republic of ... More >> Pusan National University Hospital Recruiting Busan, Korea, Republic of, 602-739 Contact: Sang Soo Kim, MD., PhD. ?? +82-51-240-7228 ?? drsskim7@gmail.com ?? Contact: Jong Ho Kim, MD. ?? +82-51-240-7983 ?? bedaya@hanmail.net Less <<
NCT01342770 Stage IA Non-Small Cell Lung C... More >>arcinoma Stage IB Non-Small Cell Lung Carcinoma Stage IIA Non-Small Cell Lung Carcinoma Stage IIB Non-Small Cell Lung Carcinoma Stage IIIA Non-Small Cell Lung Cancer Less << Phase 2 Terminated - United States, Minnesota ... More >> Mayo Clinic Rochester, Minnesota, United States, 55905 Less <<
NCT01342770 - Terminated - -
NCT02027103 Type 2 Diabetes Mellitus Not Applicable Completed - Iran, Islamic Republic of ... More >> Diabetes Clinic, Vali-Asr Hospital, Tehran University of Medical Sciences Tehran, Iran, Islamic Republic of, 13145-784 Less <<
NCT01040819 Type 2 Diabetes Mellitus PHASE4 COMPLETED 2025-12-11 Baylor Clinics, Houston, Texas... More >>, 77030, United States|Baylor College of Medicine, HOuston, Texas, 77030, United States Less <<
NCT01040819 Type 2 Diabetes Mellitus PHASE4 COMPLETED 2025-12-11 Baylor Clinics, Houston, Texas... More >>, 77030, United States|Baylor College of Medicine, HOuston, Texas, 77030, United States Less <<
NCT00782795 - Completed - -
NCT00782795 Chronic Pancreatitis ... More >> Insulin Resistance Normal or Mildly Abnormal Stool Fat Levels Less << Phase 2 Completed - United States, Michigan ... More >> University of Michigan Health System Ann Arbor, Michigan, United States, 48109 Less <<
NCT00656864 Diabetes Mellitus, Type 2 Phase 4 Completed - United States, Vermont ... More >> University of Vermont South Burlington, Vermont, United States, 05403 Less <<
NCT02585765 Spinal Cord Injury ... More >> Pressure Ulcers Less << Phase 2 Withdrawn(an alternate plan of... More >> investigation was developed.) Less << - United States, New York ... More >> James J. Peters VA Medical Center Bronx, New York, United States, 10468 Less <<
NCT01717040 Bipolar Disorder ... More >> Insulin Resistance Less << Phase 4 Terminated(The study ended ear... More >>ly due to budgetary issues) Less << - United States, Ohio ... More >> University Hospitals Cleveland Medical Center - Mood Disorders Program Cleveland, Ohio, United States, 44106 Less <<
NCT01717040 - Terminated(The study ended ear... More >>ly due to budgetary issues) Less << - -
NCT00545857 Type 1 Diabetes Mellitus Phase 1 Completed - United States, New York ... More >> Thomas A. Wilson, MD Stony Brook, New York, United States, 11794-8111 Less <<
NCT00672919 Diabetes Mellitus PHASE4 COMPLETED 2025-08-04 Birmingham,, Alabama, United S... More >>tates|Tucson, Arizona, United States|Bellflower, California, United States|Burlingame, California, United States|Fresno,, California, United States|La Jolla, California, United States|Long Beach, California, United States|Pasadena, California, United States|Arvada, Colorado, United States|Norwalk, Connecticut, United States|Waterbury, Connecticut, United States|Aventura, Florida, United States|Hollywood, Florida, United States|Jacksonville, Florida, United States|Miami, Florida, United States|N. Miami Beach, Florida, United States|Tallahassee, Florida, United States|West Palm Beach, Florida, United States|Columbus,, Georgia, United States|Idaho Falls, Idaho, United States|Chicago Heights, Illinois, United States|Evansville,, Indiana, United States|Des Moines, Iowa, United States|Lafayette, Louisiana, United States|Fall River, Massachusetts, United States|Waltham, Massachusetts, United States|Tupelo, Mississippi, United States|Chesterfield, Missouri, United States|Omaha, Nebraska, United States|Staten Island, New York, United States|Raleigh, North Carolina, United States|Winston-Salem, North Carolina, United States|Centerville, Ohio, United States|Dayton, Ohio, United States|Medford, Oregon, United States|Meadville, Pennsylvania, United States|Pittsburgh, Pennsylvania, United States|Warwick, Rhode Island, United States|Chattanooga, Tennessee, United States|Morristown, Tennessee, United States|Murfreesboro, Tennessee, United States|Nashville, Tennessee, United States|Arlington, Texas, United States|Houston, Texas, United States|Midland, Texas, United States|San Antonio, Texas, United States|Ogden, Utah, United States|Orange, Virginia, United States|Virginia Beach,, Virginia, United States|Man, West Virginia, United States|Wausau, Wisconsin, United States|Carolina, Puerto Rico|PoncE, Puerto Rico Less <<
NCT02303405 Diabetes Mellitus Type 2 With ... More >>Hyperglycemia Less << Phase 2 Terminated(Investigator decisi... More >>on) Less << - United States, California ... More >> Charles Drew University of Medicine and Science Los Angeles, California, United States, 90059 Less <<
NCT01472497 Hypertension|Insulin Resistanc... More >>e Less << PHASE4 COMPLETED 2025-03-12 Tottori University Hospital, Y... More >>onago, 683-8504, Japan Less <<
NCT00322868 Cystic Fibrosis Not Applicable Completed - United States, Ohio ... More >> Rainbow Babies and Children's Hospital Cleveland, Ohio, United States, 44106 Less <<
NCT00322868 - Completed - -
NCT01341730 Atherosclerosis ... More >> Coronary Artery Disease Less << Phase 4 Completed - Korea, Republic of ... More >> Cardiovascular center, Seoul St. Mary's hospital Seoul, Korea, Republic of, 137-701 Less <<
NCT00708175 Bone Metabolism Phase 4 Completed - -
NCT00708175 - Completed - -
NCT00609856 Type 2 Diabetes ... More >> Secondary Drug Failure Less << Phase 4 Completed - Sweden ... More >> Malm? University Hospital Malm?, Sweden, 20502 Less <<
NCT00923949 Non-Small-Cell Lung Cancer PHASE2 TERMINATED 2025-03-10 National Institutes of Health ... More >>Clinical Center, 9000 Rockville Pike, Bethesda, Maryland, 20892, United States|New York University, New York, New York, 10016, United States Less <<
NCT00923949 Non-Small-Cell Lung Cancer PHASE2 TERMINATED 2025-03-10 National Institutes of Health ... More >>Clinical Center, 9000 Rockville Pike, Bethesda, Maryland, 20892, United States|New York University, New York, New York, 10016, United States Less <<
NCT00676260 Diabetes Mellitus Phase 2 Completed - United Kingdom ... More >> Exeter, United Kingdom Less <<
NCT02099838 Diabetes Mellitus, Type 2 Phase 4 Completed - China, Hubei ... More >> Tongji Hospital Wuhan, Hubei, China, 430030 Less <<
NCT02099838 - Completed - -
NCT01559857 Major Depressive Disorder ... More >> Insulin Resistance Less << Phase 4 Completed - United States, California ... More >> Stanford University Department of Psychiatry & Behavioral Sciences Palo Alto, California, United States, 94305 Less <<
NCT01559857 - Completed - -
NCT01972724 - Completed - -
NCT01972724 Type II Diabetes Mellitus Phase 4 Completed - Korea, Republic of ... More >> Chagwon, Korea, Republic of Daegu, Korea, Republic of Daejeon, Korea, Republic of Gwangju, Korea, Republic of Gyeonggi-do, Korea, Republic of Jeonju, Korea, Republic of Seoul, Korea, Republic of Ulsan, Korea, Republic of Wonju, Korea, Republic of Less <<
NCT01395784 - Completed - -
NCT02429232 Osteoporosis ... More >>Diabetes Mellitus Less << Phase 4 Unknown December 2017 -
NCT01395784 Opioid Abuse Phase 2 Completed - United States, New York ... More >> Columbia Univ/ NYSPI Division on Substance Abuse New York, New York, United States, 10032 Less <<
NCT00927290 Chronic Hepatitis C ... More >> Insulin Resistance Less << Phase 3 Terminated(Suspension of use o... More >>f medicine containing Pioglitazone by French regulatory agency) Less << - France ... More >> H?pital Pitié Salpêtrière, Service d'hépatogastroentérologie Paris, France, 75013 Less <<
NCT03566225 Pioglitazone Early Phase 1 Not yet recruiting December 25, 2018 -
NCT00994682 Nonalcoholic Steatohepatitis ... More >> Nonalcoholic Fatty Liver Disease Type 2 Diabetes Mellitus Less << Phase 4 Completed - United States, Texas ... More >> Bartter Research Unit, Audie L Murphy VA Hospital San Antonio, Texas, United States, 78248 Less <<
NCT00994682 - Completed - -
NCT03125694 Uncontrolled Type 2 Diabetes M... More >>ellitus Less << Phase 3 Completed - Iran, Islamic Republic of ... More >> Tehran University of Medical Sciences Tehran, Iran, Islamic Republic of Less <<
NCT01947790 LVM Type 2 Di... More >>abetic Patients With IHD Endothelial Function Less << Phase 4 Completed - China, Hubei ... More >> Wuhan City, Hubei, China, 43000 Xiang Guangda Wuhan, Hubei, China, 430070 Less <<
NCT01990300 - Completed - -
NCT01309854 Rheumatoid Arthritis ... More >> Healthy Volunteers Pharmacokinetics Pioglitazone Drug-drug Interaction Amount of Pioglitazone in Blood Less << Phase 1 Completed - United States, Kansas ... More >> Research Site Overland Park, Kansas, United States Less <<
NCT01082120 Type 2 Diabetes Mellitus Phase 1 Completed - United States, California ... More >> Research Site Chula Vista, California, United States Less <<
NCT00770367 Diabetes Phase 4 Completed - United States, South Carolina ... More >> Department of Family Medicine, MUSC Charleston, South Carolina, United States, 29425 Less <<
NCT00770367 - Completed - -
NCT01195090 Type 2 Diabetes Phase 4 Completed - Taiwan ... More >> Division of Endocrinology and Metabolism, Department of Internal Medicine, Mackay Memorial Hospital Taipei, Taiwan, 10449 Less <<
NCT01456117 Healthy Phase 1 Completed - United States, North Carolina ... More >> Durham, North Carolina, United States Less <<
NCT02098746 - Completed - -
NCT02098746 - Completed - -
NCT01695707 Atopic Dermatitis Not Applicable Withdrawn(Insufficient Funding... More >>.) Less << June 2014 United States, New York ... More >> University of Rochester Medical Center Rochester, New York, United States, 14642 Less <<
NCT01195090 - Completed - -
NCT01838317 Cancer of the Pancreas PHASE2 COMPLETED 2017-09-20 UT Southwestern Medical Center... More >>, Dallas, Texas, 75390, United States Less <<
NCT00855010 Obesity Type ... More >>2 Diabetes Less << Not Applicable Completed - United States, Texas ... More >> UT Southwestern Medical Center Dallas, Texas, United States, 75390 Less <<
NCT00855010 - Completed - -
NCT02068508 Type 2 Diabetes Mellitus COMPLETED 2014-06-30 -
NCT01280123 Parkinson's Disease Phase 2 Completed - -
NCT01280123 - Completed - -
NCT01253928 ESRD PHASE4 UNKNOWN - Nephrology Service Department ... More >>of Medicine CHUV, Lausanne, Vaud, 1011, Switzerland Less <<
NCT02003014 Type 2 Diabetes Mellitus COMPLETED 2025-01-12 -
NCT02003014 Type 2 Diabetes Mellitus COMPLETED 2025-01-12 -
NCT01001013 Healthy Phase 1 Completed - Korea, Republic of ... More >> Seoul National University Hospital Seoul, Korea, Republic of Less <<
NCT01186250 Cardiac Allograft Vasculopathy Phase 2 Completed - United States, California ... More >> Stanford University School of Medicine Stanford, California, United States, 94305 Less <<
NCT01186250 - Completed - -
NCT02002975 Type 2 Diabetes Mellitus COMPLETED 2013-06-30 -
NCT00835120 Metabolic Syndrome|Bipolar Dep... More >>ression|Insulin Resistance Less << PHASE4 COMPLETED 2025-04-13 University Hospitals Cleveland... More >> Medical Center, Cleveland, Ohio, 44106, United States Less <<
NCT00835120 Metabolic Syndrome|Bipolar Dep... More >>ression|Insulin Resistance Less << PHASE4 COMPLETED 2025-04-13 University Hospitals Cleveland... More >> Medical Center, Cleveland, Ohio, 44106, United States Less <<
NCT01156597 Type 2 Diabetes Mellitus Phase 3 Completed - United States, Florida ... More >> Diabetes Research Institute Miami, Florida, United States, 33136 Less <<
NCT01258322 Peritoneal Dialysis|Pioglitazo... More >>ne|Hypertriglyceridemia|Insulin Resistance|Inflammation Less << COMPLETED 2025-09-08 -
NCT01156597 - Completed - -
NCT00811681 Friedreich's Ataxia Phase 3 Completed - France ... More >> H?pital Robert Debré Paris, France, 75019 Less <<
NCT00861341 Diabetes Plat... More >>elet Function Healthy Less << Phase 2 Completed - United States, New York ... More >> University of Rochester Rochester, New York, United States, 14642 Less <<
NCT01068444 Hepatitis Phase 2 Recruiting March 2019 Taiwan ... More >> Kaohsiung Municipal Hsiao-Kang Hospital, Kaohsiung Medical University Recruiting Kaohsiung City, Taiwan, 812 Contact: Jee-Fu Huang, MD. ?? 88678036783 ext 3440 ?? jf71218@gmail.com ?? Principal Investigator: Wan-Long Chuang, MD., PhD. ?? ?? ?? Kaohsiung Medical University Hospital Recruiting Kaohsiung, Taiwan, 803 Contact: Wan-Long Chuang, MD, PhD ?? 886 7 3208282 ?? waloch@kmu.edu.tw; research.kmuhb@gmail.com ?? Principal Investigator: Wan-Long Chuang, MD, PhD Less <<
NCT01819402 To Evaluate the Effect of Piog... More >>litazone on Glucose Metabolism of Fat Tissue by Using FDG-PET/CT Imaging Less << Not Applicable Unknown - Japan ... More >> Kurume University Recruiting Kurume, Japan, 830-0011 Contact: Nobuhiro Tahara, MD, PhD ?? +81-942-31-7580 ?? ntahara@med.kurume-u.ac.jp Less <<
NCT01223196 Type 2 Diabetes Phase 4 Completed - United States, Texas ... More >> Bartter Research Unit , ALM VA Hospital San Antonio, Texas, United States, 78229 Less <<
NCT01223196 - Completed - -
NCT00845182 Type 2 Diabetes ... More >> Healthy Impaired Glucose Tolerance Less << Phase 4 Completed - United States, Texas ... More >> Barter Research Center, ALM VA Hospital San Antonio, Texas, United States, 78229 Less <<
NCT00845182 - Completed - -
NCT01151670 Brain Neoplasms, Malignant ... More >> Brain Neoplasms, Benign Malignant Meningioma Glioblastoma Multiforme Anaplastic Astrocytoma Less << Phase 1 Completed - United States, North Carolina ... More >> Wake Forest University Health Sciences Winston-Salem, North Carolina, United States, 27157 Less <<
NCT01589445 Type 2 Diabetes Mellitus Phase 4 Completed - Bangladesh ... More >> Bangladesh Institute of Research and Rehabilitation in Diabetes, Endocrine and Metabolic Disorders (BIRDEM) Dhaka, Bangladesh, 1000 Less <<
NCT01589445 - Completed - -
NCT01090752 Diabetes Hype... More >>rtension Less << Phase 4 Completed - Switzerland ... More >> Pechère-Bertschi Antoinette Geneva, Switzerland, 1211 Less <<
NCT01090752 - Completed - -
NCT01396564 Type 2 Diabetes Phase 1 Phase 2 Completed - Mexico ... More >> Endocrine Outpatient Clinic of the Hospital de Pediatria del CMN "Siglo XXI" Mexico City, DF, Mexico, 06720 Less <<
NCT01655719 Thyroid Cancers That Contain t... More >>he PAX8-PPARgamma Fusion Gene Less << PHASE2 COMPLETED 2017-03-31 University of Colorado, Aurora... More >>, Colorado, 80045, United States|University of Michigan, Ann Arbor, Michigan, 48109, United States|University of Pennsylvania, Philadelphia, Pennsylvania, 19104, United States|University of Texas MD Anderson Cancer Center, Houston, Texas, 77030, United States Less <<
NCT01655719 Thyroid Cancers That Contain t... More >>he PAX8-PPARgamma Fusion Gene Less << PHASE2 COMPLETED 2017-03-31 University of Colorado, Aurora... More >>, Colorado, 80045, United States|University of Michigan, Ann Arbor, Michigan, 48109, United States|University of Pennsylvania, Philadelphia, Pennsylvania, 19104, United States|University of Texas MD Anderson Cancer Center, Houston, Texas, 77030, United States Less <<
NCT01352182 Severe Sepsis ... More >> Septic Shock Less << Phase 1 Phase 2 Completed - United States, Ohio ... More >> Cincinnati Children's Hospital Medical Center Cincinnati, Ohio, United States, 45229 Less <<
NCT02284906 Mild Cognitive Impairment Due ... More >>to Alzheimer's Disease Less << Phase 3 Terminated(Lack of efficacy of... More >> the drug; no safety concern) Less << - -
NCT01882907 Type 2 Diabetes Phase 4 Completed - Korea, Republic of ... More >> Busan Saint Mary's Medical Center Busan, Korea, Republic of Dong-AUniversity Medical Center Busan, Korea, Republic of Inje University Baik Hospital Busan, Korea, Republic of Kosin University Hospital Busan, Korea, Republic of Pusan National University Hospital Busan, Korea, Republic of Changwon Fatima Hospital Changwon, Korea, Republic of Daegu Catholic University Medical Center Daegu, Korea, Republic of Keimyung University Dongsan Medical Center Daegu, Korea, Republic of Kyungbuk National Universtiy Hospital Daegu, Korea, Republic of Chonnam National University Hospital Gwangju, Korea, Republic of Chosun University Hospital Gwangju, Korea, Republic of Chonbuk National University Hospital Jeonju, Korea, Republic of Gyeongsang National University Hospital Jinju, Korea, Republic of Masan Samsung Medical Center Masan, Korea, Republic of Ulsan University Hospital Ulsan, Korea, Republic of Less <<
NCT01882907 - Completed - -
NCT02181842 Type 2 Diabetes Mellitus COMPLETED 2011-06-30 -
NCT01935466 Bladder Cancer COMPLETED 2025-10-21 Deptt of Endocrinology, Chandi... More >>garh, 160012, India Less <<
NCT02730195 Chronic Myelogenous Leukemia, ... More >>BCR-ABL1 Positive Recurrent Chronic Myelogenous Leukemia, BCR-ABL1 Positive Less << Phase 2 Recruiting May 2021 United States, Georgia ... More >> Emory University/Winship Cancer Institute Recruiting Atlanta, Georgia, United States, 30322 Contact: Shannon Gleason ?? 404-778-4334 ?? shannon.gleason@emory.edu Less <<
NCT01637935 Diabetes|Bladder Cancer COMPLETED 2025-08-14 -
NCT01637935 Diabetes|Bladder Cancer COMPLETED 2025-08-14 -
NCT01935804 Diabetes Mellitus ... More >> Diabetes Mellitus, Type 2 Glucose Metabolism Disorders Less << Phase 2 Completed - Saudi Arabia ... More >> Center of Excellence for Osteoporosis Research, King Abdulaziz University Jeddah, Makkah, Saudi Arabia, 21589 Less <<
NCT01931566 Mild Cognitive Impairment Due ... More >>to Alzheimer's Disease Less << Phase 3 Terminated(Lack of efficacy of... More >> the drug; no safety concern) Less << - -
NCT02133625 Advanced Solid Tumor ... More >> Metastatic Solid Tumor Less << Phase 1 Completed - United States, Massachusetts ... More >> Dana-Farber Cancer Institute Boston, Massachusetts, United States, 02115 Brigham and Women's Hospital Boston, Massachusetts, United States, 02215 Less <<
NCT03231033 Autoimmune Pulmonary Alveolar ... More >>Proteinosis Less << PHASE1 COMPLETED 2019-04-02 Cincinnati Children's Hospital... More >> Medical Center, Cincinnati, Ohio, 45229, United States Less <<
NCT03471117 Chronic Kidney Diseases Phase 4 Recruiting June 1, 2020 United States, Texas ... More >> University of Texas at Arlington Recruiting Arlington, Texas, United States, 76010 Contact: Paul J Fadel, PhD ?? 817-272-4653 ?? paul.fadel@uta.edu ?? UT Southwestern Recruiting Dallas, Texas, United States, 75390 Contact: Robert Toto, MD ?? 214-648-2744 ?? Robert.Toto@UTSouthwestern.edu Less <<
NCT03060772 Alcoholism PHASE2 TERMINATED 2020-01-28 Atlanta VA Medical Center, Dec... More >>atur, Georgia, 30033, United States Less <<
NCT02687425 Leukemia, Myelogenous, Chronic... More >>, BCR-ABL Positive Less << Phase 2 Unknown June 2017 -
NCT02697617 Polycystic Kidney Disease Phase 2 Active, not recruiting October 2020 United States, Indiana ... More >> Indiana University Health Indianapolis, Indiana, United States, 46202 Less <<
NCT02958956 Diabetes Mellitus, Type 2, Can... More >>cer Less << COMPLETED 2015-05-29 -
NCT03440034 Myositis|Inclusion Body Myosit... More >>is|Muscular Diseases|Musculoskeletal Disease|Neuromuscular Diseases|Nervous System Diseases Less << PHASE1 COMPLETED 2020-12-31 Johns Hopkins University, Balt... More >>imore, Maryland, 21224, United States Less <<
NCT03080480 Chronic Granulomatous Disease PHASE1|PHASE2 TERMINATED 2019-10-20 Children's Hospital of Fudan U... More >>niversity, Shanghai, Shanghai, 201102, China Less <<
NCT02958956 Diabetes Mellitus, Type 2, Can... More >>cer Less << COMPLETED 2015-05-29 -
NCT00461006 Diabetes Mellitus Type 2 Phase 2 Completed - -
NCT01895569 Type 2 Diabetes Mellitus Phase 4 Unknown June 2016 Italy ... More >> IRCCS Policlinico S. Matteo Foundation Recruiting Pavia, Italy, 27100 Contact: Giuseppe Derosa, MD, PhD ?? ?? giuseppe.derosa@unipv.it ?? Contact: Pamela Maffioli, MD ?? ?? pamelamaffioli@hotmail.it ?? Principal Investigator: Giuseppe Derosa, MD, PhD ?? ?? ?? Sub-Investigator: Pamela Maffioli, MD Less <<
NCT02989649 - Terminated(Business Decision; ... More >>No Safety Or Efficacy Concerns) Less << - China, Beijing ... More >> Beijing, Beijing, China China, Hubei Wuhan, Hubei, China China, Liaoning Dalian, Liaoning, China Shenyang, Liaoning, China China, Shandong Jinan, Shandong, China Qingdao, Shandong, China Tai'an, Shandong, China Taian, Shandong, China China, Tianjin Tianjin, Tianjin, China Hong Kong Sai Ying Pun, Hong Kong Sha Tin, Hong Kong Less <<
NCT00395941 Psoriasis Phase 2 Unknown - India ... More >> PGIMER Not yet recruiting Chandigarh, India, 160012 Contact: Samir Malhotra, MD, DM ?? +91-172-2755243 ?? samirmalhotra345@yahoo.com ?? Sub-Investigator: Promila Pandhi, MD,DM ?? ?? ?? Principal Investigator: Samir Malhotra, MD, DM ?? ?? ?? Sub-Investigator: Inderjeet Kaur, md ?? ?? ?? Sub-Investigator: Sunil Dogra, MD Less <<
NCT00419484 - Completed - Japan ... More >> Dokkyo Medical University, Koshigaya Hospital Koshigaya, Saitama, Japan, 343-8555 Less <<
NCT01614301 Advanced Melanoma Phase 1 Phase 2 Unknown May 2016 Germany ... More >> University of Regensburg Recruiting Regensburg, Bavaria, Germany, 93053 Contact: Albrecht Reichle, Professor ?? +499419440 ?? albrecht.reichle@UKR.de ?? Sub-Investigator: Martin Vogelhuber, MD ?? ?? ?? Sub-Investigator: Stephanie Mayer, MD ?? ?? ?? Sub-Investigator: Christina Hart, MD ?? ?? ?? Sub-Investigator: Matthias Grube, MD ?? ?? ?? Sub-Investigator: Susanne Gantner, MD Less <<
NCT00461058 Diabetes Mellitus Type 2 Phase 2 Completed - -
NCT00500331 Diabetes Mellitus, Type 2 Phase 2 Completed - -
NCT00276497 Diabetes PHASE1 COMPLETED 2025-05-08 -
NCT02739750 - Active, not recruiting October 2020 United States, Indiana ... More >> University Hospital Indianapolis, Indiana, United States, 46202 Less <<
NCT00226330 Diabetes Mellitus, Type 2 Phase 3 Terminated(The development pro... More >>gram has been terminated) Less << - -
NCT00500331 - Completed - -
NCT00426413 - Completed - United States, Georgia ... More >> Grady Memorial Hospital Atlanta, Georgia, United States, 30303 Less <<
NCT02823808 Diabetes Phase 4 Recruiting December 2021 Korea, Republic of ... More >> Kyunghee University Medical Center Recruiting Seoul, Korea, Republic of Contact: Sang Youl Rhee Less <<
NCT00384215 Diabetes Mellitus, Type 2 Phase 4 Completed - United States, New Jersey ... More >> Sanofi-Aventis Bridgewater, New Jersey, United States, 08807 Less <<
NCT00219440 Diabetes Mellitus Phase 4 Completed - United States, Louisiana ... More >> Pennington Center Baton Rouge, Louisiana, United States, 70808 Less <<
NCT00656851 HIV Infections ... More >> Cardiovascular Disease Insulin Resistance HIV Lipodystrophy The Metabolic Syndrome Less << Not Applicable Completed - United States, Missouri ... More >> Washington University School of Medicine St. Louis, Missouri, United States, 63110 Less <<
NCT00086502 Diabetes Mellitus, Type 2 Phase 3 Completed - -
NCT01175486 Diabetes Phase 4 Unknown December 2015 Taiwan ... More >> Taipei Veterans General Hospital, Taiwan Recruiting Taipei, Taiwan Principal Investigator: Harn-Shen Chen, MD, PhD Less <<
NCT00656851 - Completed - -
NCT00086502 - Completed - -
NCT01133561 Psoriasis Not Applicable Completed - Egypt ... More >> Dermatology department of cairo university faculty of medicine Cairo, Egypt Less <<
NCT01006018 - Terminated(Unanticipated delay... More >>s due to sterilization/stabilization testing of GLP-1.) Less << - -
NCT01006018 Prediabetic State Not Applicable Terminated(Unanticipated delay... More >>s due to sterilization/stabilization testing of GLP-1.) Less << - United States, Georgia ... More >> Grady Memorial Hospital Atlanta, Georgia, United States, 30303 Emory University Hospital Atlanta, Georgia, United States, 30322 Less <<
NCT01909141 Polycystic Ovary Syndrome ... More >> Infertility Less << Early Phase 1 Completed - Egypt ... More >> Cairo University Cairo, Egypt Less <<
NCT00904046 Uric Acid Kidney Stone Disease Not Applicable Recruiting December 2019 United States, Texas ... More >> UT Southwestern Medical Center - Center for Mineral Metabolism Recruiting Dallas, Texas, United States, 75390-8885 Less <<
NCT00145340 Polycystic Ovary Syndrome Phase 4 Completed - Denmark ... More >> Department of Endocrinology, Odense University Hospital Odense, Funen, Denmark, 5000 Less <<
NCT00240370 Type 2 Diabetes Phase 3 Completed - -
NCT02133118 - Completed - Netherlands ... More >> Isala Zwolle, Overijssel, Netherlands, 8000 AB Less <<
NCT01909141 - Completed - -
NCT00867126 Pancreatic Cancer Early Phase 1 Terminated(low accrual) - United States, Texas ... More >> Simmons Comprehensive Cancer Center at University of Texas Southwestern Medical Center - Dallas Dallas, Texas, United States, 75390 Less <<
NCT01043029 Diabetes Mellitus Type 2 Phase 2 Completed - -
NCT00744367 Diabetes Mellitus Type 2 Phase 3 Completed - -
NCT00269061 Non-Insulin-Dependent Diabetes... More >> Mellitus Less << Phase 1 Completed - United States, Massachusetts ... More >> GSK Investigational Site Belmont, Massachusetts, United States, 02478 Less <<
NCT00554853 Rheumatoid Arthritis Phase 3 Completed - United States, Michigan ... More >> University of Michigan Ann Arbor, Michigan, United States, 48109 Less <<
NCT00554853 - Completed - -
NCT00700856 Type 2 Diabetes Mellitus ... More >> Cardiovascular Disease Less << Phase 4 Unknown December 2018 -
NCT00885352 - Completed - -
NCT00885352 Type 2 Diabetes Mellitus Phase 3 Completed - -
NCT01183013 Diabetes Mellitus, Type 2 Phase 3 Completed - -
NCT00763139 Rheumatoid Arthritis Not Applicable Completed - United States, Tennessee ... More >> Vanderbilt Clinical Research Center Nashville, Tennessee, United States, 37232-2195 Less <<
NCT00763139 - Completed - -
NCT00631007 Type 2 Diabetes Mellitus Phase 2 Completed - -
NCT00631007 - Completed - -
NCT01183013 - Completed - -
NCT00511108 Type 2 Diabetes Mellitus (T2DM... More >>) Less << Phase 1 Completed - -
NCT00511108 - Completed - -
NCT01107717 Diabetes Not Applicable Recruiting December 2024 United States, Texas ... More >> Texas Diabetes Institute Recruiting San Antonio, Texas, United States, 78229-3900 Contact: Muhammad Abdul-Ghani, MD, PhD ?? 210-567-2391 ?? ABDULGHANI@UTHSCSA.EDU ?? Contact: Curtiss Puckett, PA ?? (210) 358 7200 ?? Curtiss.Puckett@uhs-sa.com ?? Principal Investigator: Ralph DeFronzo, MD Less <<
NCT00470262 - Completed - -
NCT01631630 - Terminated(The study was close... More >>d to recruitment due to feasibility problems.) Less << - -
NCT00470262 Metabolic Syndrome X ... More >> Prediabetic State Less << Not Applicable Completed - United States, Colorado ... More >> VA Eastern Colorado Health Care System, Denver Denver, Colorado, United States, 80220 Less <<
NCT01432405 Type 2 Diabetes Mellitus Phase 4 Completed - United States, Texas ... More >> Baylor College of Medicine Houston, Texas, United States, 77030 Less <<
NCT01432405 - Completed - -
NCT00571506 Diabetes Mellitus, Type 2 ... More >> Vascular Diseases Less << Phase 4 Completed - United States, Arkansas ... More >> University of Arkansas for Medical Sciences Little Rock, Arkansas, United States, 72205 Less <<
NCT01570660 Type 2 Diabetes Mellitus COMPLETED 2025-03-12 Medical University of Vienna, ... More >>Vienna, Austria Less <<
NCT00306826 Glucose Metabolism Disorders Phase 4 Withdrawn(financial support wi... More >>thdrawn) Less << - Germany ... More >> Praxis Antje Horn Gera, Germany, 07548 Praxis Gunter K?ssner Leipzig, Germany, 04229 Praxis Heidrun T?schner Leipzig, Germany, 04249 Praxis Martin Sch?nauer Leipzig, Germany, 04275 University of Leipzig Heart Center Leipzig, Germany, 04289 Praxis Matthias Weissbrodt Leipzig, Germany, 04299 Praxis Matthias Schreiner Leipzig, Germany, 04357 Less <<
NCT01346254 Impaired Glucose Tolerance ... More >> Kidney Transplantation Less << Phase 2 Completed - Austria ... More >> Allgemeines Krankenhaus der Stadt Wien, Universit?tskliniken Wien, Austria, 1090 Less <<
NCT01631630 Alcohol Dependence ... More >> Alcohol Drinking Stress Alcohol-Related Disorders Less << Phase 2 Terminated(The study was close... More >>d to recruitment due to feasibility problems.) Less << - United States, Maryland ... More >> National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States, 20892 Less <<
NCT02172235 Healthy Phase 1 Completed - -
NCT00352287 Obesity Metab... More >>olic Syndrome Impaired Glucose Tolerance Less << Phase 4 Completed - United States, California ... More >> Veterans Affairs Palo Alto Health Care System Palo Alto, California, United States, 94304 Less <<
NCT00154037 Healthy Subjects Not Applicable Completed - Germany ... More >> Institute of Clinical Pharmacology, Medical Faculty, University of Technology Dresden, Germany, 01307 Less <<
NCT03196362 Type 2 Diabetes Mellitus Phase 4 Recruiting December 31, 2018 China, Guangdong ... More >> endocrinology department of the first affiliated hospital of Sun Yat-sen University Recruiting Guangzhou, Guangdong, China, 510080 Contact: Yanbing Li, MD,PhD ?? 8602087334331 ?? easd04lyb@126.com ?? Principal Investigator: Yanbing Li, MD,PhD Less <<
NCT01106690 Diabetes Mellitus, Type 2 Phase 3 Completed - -
NCT00232362 Type 2 Diabetes Mellitus Phase 1 Withdrawn(This study was not c... More >>onducted as the Principal Investigator left the institution) Less << June 2008 -
NCT02875821 Type 2 Diabetes With Non-alcoh... More >>olic Fatty Liver (NAFLD) Less << Phase 4 Completed - Korea, Republic of ... More >> Yonsei University College of Medicine, Department of internal Medicine, Division of Endocrinology, Severance Hospital, Diabetes Center Seoul, Korea, Republic of, 03722 Less <<
NCT01800227 Healthy Phase 1 Completed - India ... More >> Bio Evaluation Centre, Torrent Pharmaceuticals Ltd., Village Bhat, Gandhinagar, Gujarat, India Less <<
NCT01106690 - Completed - -
NCT01165190 - Unknown - United States, Arizona ... More >> Clinical Research Unit Recruiting 550 East Orange Street, Arizona, United States, 85287 Contact: Christian Meyer, MD ?? (480) 965-2473 ?? Christian.Meyer@asu.edu Less <<
NCT02763007 Diabetes Mellitus, Type 2 Phase 4 Recruiting September 2020 Korea, Republic of ... More >> Seoul St Mary's Hospital, The Catholic University of Korea Recruiting Seoul, Korea, Republic of, 137-701 Contact: YOON HEE CHOI, MD ?? ?? ?? Principal Investigator: Kun-Ho Yoon, MD, PhD ?? ?? ?? Sub-Investigator: Yoon-Hee Choi, MD, PhD ?? ?? ?? Sub-Investigator: Eun-Young Lee, MD, PhD Less <<
NCT00815399 Type 2 Diabetes Phase 4 Completed - Italy ... More >> Department of Geriatrics and Metabolic Diseases Naples, Italy, 80138 Less <<
NCT01800240 Healthy Phase 1 Completed - India ... More >> Bio Evaluation Centre, Torrent Pharmaceuticals Ltd., Village Bhat, Gandhinagar, Gujarat, India Less <<
NCT00763815 Diabetes Mellitus Type 2 Phase 3 Completed - -
NCT00579813 Metabolic Syndrome|Insulin Res... More >>istance|Prediabetes Less << PHASE4 COMPLETED 2025-01-11 University of Arkansas for Med... More >>ical Sciences, Little Rock, Arkansas, 72205, United States|University of Kentucky, Lexington, Kentucky, 40536, United States Less <<
NCT00372060 Type 2 Diabetes Mellitus Phase 3 Completed - -
NCT00970424 Diabetes Mellitus, Type II Phase 3 Terminated - -
NCT00579813 Metabolic Syndrome|Insulin Res... More >>istance|Prediabetes Less << PHASE4 COMPLETED 2025-01-11 University of Arkansas for Med... More >>ical Sciences, Little Rock, Arkansas, 72205, United States|University of Kentucky, Lexington, Kentucky, 40536, United States Less <<
NCT00106808 Type 2 Diabetes Mellitus Phase 3 Completed - -
NCT00399204 Type 2 Diabetes Phase 4 Unknown - India ... More >> PGIMER Recruiting Chandigarh, India, 160012 Contact: Samir Malhotra, MD, DM ?? ?? samirmalhotra345@yahoo.com ?? Sub-Investigator: Samir Malhotra, MD,DM Less <<
NCT00763815 - Completed - -
NCT00762736 Diabetes Mellitus Phase 2 Completed - -
NCT00909597 Diabetes Mellitus Type 2 Phase 3 Completed - -
NCT00372060 - Completed - -
NCT01395797 Heroin Dependence ... More >> Nicotine Dependence Less << Phase 1 Phase 2 Terminated(The funding period ... More >>ended.) Less << - United States, New York ... More >> New York State Psychiatric Institute New York, New York, United States, 10032 Less <<
NCT01395797 - Terminated(The funding period ... More >>ended.) Less << - -
NCT00665353 - Completed - -
NCT00151710 Congenital Adrenal Hyperplasia COMPLETED - Radboud University Nijmegen Me... More >>dical Centre, Nijmegen, Gelderland, 6500 HB, Netherlands Less <<
NCT01797666 Healthy Phase 1 Completed - India ... More >> Bio Evaluation Centre, Torrent Pharmaceuticals Ltd., Village Bhat, Gandhinagar, Gujarat, India Less <<
NCT00665353 HIV-1 and Hepatitis C Co-Infec... More >>tion Less << Phase 2 Completed - United States, California ... More >> Ucsf Aids Crs (801) San Francisco, California, United States, 94110 United States, Illinois Northwestern University CRS (2701) Chicago, Illinois, United States, 60611 United States, New Jersey New Jersey Medical School-Adult Clinical Research Ctr. CRS (31477) Newark, New Jersey, United States, 07103 United States, New York Cornell CRS (7804) New York, New York, United States, 10011 NY Univ. HIV/AIDS CRS (401) New York, New York, United States, 10016 AIDS Care CRS (1108) Rochester, New York, United States, 14642 United States, Ohio Metro Health CRS (2503) Cleveland, Ohio, United States, 44109 United States, Virginia Virginia Commonwealth Univ. Medical Ctr. CRS (31475) Richmond, Virginia, United States, 23219 Less <<
NCT00013598 Fatty Liver|Nonalcoholic Steat... More >>ohepatitis Less << PHASE2 COMPLETED 2025-03-04 National Institute of Diabetes... More >> and Digestive and Kidney Diseases (NIDDK), Bethesda, Maryland, 20892, United States Less <<
NCT01088594 Type 2 Diabetes Mellitus Phase 1 Completed - United Kingdom ... More >> S337.1.004 Site # London, United Kingdom Less <<
NCT01135394 Type 2 Diabetes COMPLETED 2018-05-31 University of Maryland School ... More >>of Medicine, Baltimore, Maryland, 21201, United States Less <<
NCT00063622 Liver Diseases Phase 3 Completed - United States, California ... More >> University of California, San Diego San Diego, California, United States, 92103 University of California, San Francisco San Francisco, California, United States, 94143 United States, Indiana Indiana University Indianapolis, Indiana, United States, 46202 United States, Missouri St. Louis University Saint Louis, Missouri, United States, 63110 United States, North Carolina Duke University Medical Center Durham, North Carolina, United States, 27710 United States, Ohio Case Western Reserve University Cleveland, Ohio, United States, 44109 United States, Virginia Virginia Commonwealth University Richmond, Virginia, United States, 23298 United States, Washington University of Washington Seattle, Washington, United States, 98195 Less <<
NCT00953498 Type 2 Diabetes Phase 4 Completed - France ... More >> Service Endocrinologie-diabétologie, H?pital du Bocage CHU Dijon, France, 21000 Less <<
NCT00926614 Hepatitis c Phase 4 Completed - United States, Texas ... More >> Brooke Army Medical Center San Antonio, Texas, United States, 78234 Less <<
NCT02753803 Type 2 Diabetes Phase 1 Completed - Korea, Republic of ... More >> Clinical Trials Center, Seoul National University Hospital Seoul, Korea, Republic of, 03080 Less <<
NCT00720577 Peripheral Arterial Disease Early Phase 1 Completed - -
NCT00159211 Type 2 Diabetes Not Applicable Terminated(inclusion was finis... More >>hed) Less << - France ... More >> Sce de Diabétologie, h?pital de la Pitié-salpêtrière, 83bld de l'h?pital Paris, France, 75013 Less <<
NCT01431521 Non-alcoholic Fatty Liver Dise... More >>ase Less << Phase 1 Completed - -
NCT01431521 - Completed - -
NCT00722371 Type 2 Diabetes Mellitus Phase 3 Completed - -
NCT01798940 Healthy Phase 1 Completed - India ... More >> Bio Evaluation Centre, Torrent Pharmaceuticals Ltd., Village Bhat, Gandhinagar, Gujarat, India Less <<
NCT01612858 Lipodystrophy ... More >> HIV Infection Less << Phase 4 Completed - United States, Massachusetts ... More >> Tufts Medical Center Boston, Massachusetts, United States, 02111 Less <<
NCT01612858 - Completed - -
NCT00314561 Metabolic Syndrome Phase 4 Completed - Korea, Republic of ... More >> Korea University Anam Hospital Seoul, Korea, Republic of, 136-705 Less <<
NCT00722371 - Completed - -
NCT00433069 Chronic Hepatitis C Phase 2 Completed - Switzerland ... More >> Service de Gastroentérologie et d'Hépatologie, University Hospital Geneva, GE, Switzerland, 1211 Less <<
NCT02098733 - Completed - -
NCT00827892 Intracerebral Hemorrhage Phase 2 Completed - United States, Texas ... More >> Memorial Hermann Hospital Houston, Texas, United States, 77030 Less <<
NCT00482183 Coronary Artery Disease|Type 2... More >> Diabetes Mellitus Less << PHASE2|PHASE3 COMPLETED 2025-06-07 -
NCT02098733 - Completed - -
NCT00641043 Diabetes Mellitus, Type 2 Phase 3 Completed - -
NCT00641043 - Completed - -
NCT02887625 Type 2 Diabetes Not Applicable Unknown May 2017 Qatar ... More >> Hamad General Hospital Recruiting Doha, Qatar Contact: Osama Mujahed, MD ?? 66703172 ?? pvedromigahid@gmail.com ?? Contact: Ayman Mujahed, MD ?? 44391208 ?? ymndodo20@gmail.com Less <<
NCT00787644 Asthma Obesit... More >>y Less << Phase 2 Terminated(new safety concerns... More >> which emerged about pioglitazone during the trial) Less << - United States, Vermont ... More >> The Vermont Lung Center at the University of Vermont Colchester, Vermont, United States, 05446 Less <<
NCT00604578 Asthma Airway... More >> Inflammation Airflow Obstruction Airway Hyperactivity Less << Phase 2 Withdrawn October 30, 2009 United States, Maryland ... More >> National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States, 20892 United States, Virginia Fairfax Hospital Falls Church, Virginia, United States, 22046 Less <<
NCT00787644 - Terminated(new safety concerns... More >> which emerged about pioglitazone during the trial) Less << - -
NCT00148850 HIV-Associated Lipodystrophy S... More >>yndrome|HIV Infections Less << PHASE3 TERMINATED 2025-10-04 Service des Maladies Infectieu... More >>ses et Tropicales, Hopital Tenon, Paris, 75020, France Less <<
NCT00927355 Osteoblast Ad... More >>ipocytes Bone Density Osteocalcin Adiponectin Mesenchymal Stem Cells Less << Not Applicable Completed - United States, Georgia ... More >> Grady Diabetes Clinic Atlanta, Georgia, United States, 30303 Less <<
NCT02888964 Leukemia, Myeloid, Chronic-Pha... More >>se Less << Phase 2 Completed - France ... More >> CHR Annecy Annecy, France Institut Bergonié Bordeaux, France CH Versailles Le Chesnay, France CHU Lille Lille, France IPC Marseille, France CHU archet 1 Nice, France St Louis Paris, France CHU Poitiers Poitiers, France CHU Purpan Toulouse, France Less <<
NCT00927355 - Completed - -
NCT00722631 Impaired Glucose Tolerance ... More >> Type 2 Diabetes Mellitus Atherosclerosis Less << Not Applicable Completed - Japan ... More >> Kurume University Hospital Kurume city, Japan, 830-0011 Less <<
NCT03011775 Adverse Effect ... More >> Atherosclerosis, Coronary Insulin Resistance Syndrome Less << Phase 4 Completed - Ukraine ... More >> Ukrainian Medical Stomatological Academy Poltava, Ukraine, 36011 Less <<
NCT00649558 Healthy Phase 1 Completed - United States, North Dakota ... More >> PRACS Institute, Ltd. Fargo, North Dakota, United States, 58104 Less <<
NCT00364988 Type 2 Diabetes ... More >> Diabetic Nephropathy Less << Not Applicable Completed - -
NCT02347813 Squamous Cell Carcinoma of the... More >> Skin Less << PHASE2 COMPLETED 2019-06-01 -
NCT00649012 Healthy Phase 1 Completed - United States, North Dakota ... More >> PRACS Institute, Ltd. Fargo, North Dakota, United States, 58104 Less <<
NCT00099853 Diabetes Mellitus, Type 2 Phase 3 Completed - United States, New Jersey ... More >> Novartis Pharmaceuticals East Hanover, New Jersey, United States, 07936 Less <<
NCT01009580 Diabetes Diab... More >>etes Mellitus, Type 2 Less << Phase 3 Completed - -
NCT03720366 Leukemia, Myeloid, Acute Phase 1 Not yet recruiting December 30, 2022 -
NCT00094757 - Completed - -
NCT01009580 - Completed - -
NCT00722917 Diabetes Mellitus Phase 2 Terminated(Animal Toxicity Fin... More >>dings) Less << - United States, California ... More >> Artesia, California, United States Norwalk, California, United States Santa Ana, California, United States Santa Monica, California, United States United States, Florida Panama City, Florida, United States United States, Rhode Island Cranston, Rhode Island, United States United States, Texas Dallas, Texas, United States Houston, Texas, United States Less <<
NCT00094757 Diabetes Mellitus, Type 2 Phase 3 Completed - -
NCT03457597 Healthy Phase 1 Completed - United States, Arizona ... More >> Celerion Tempe, Arizona, United States, 85283 Less <<
NCT00280865 Type 2 Diabetes Phase 2 Completed - -
NCT00694759 Polycystic Ovary Syndrome Not Applicable Unknown July 2011 United States, Oregon ... More >> Oregon Health & Science University Recruiting Portland, Oregon, United States, 97239 Principal Investigator: Bethany J. Klopfenstein, MD Less <<
NCT01134835 Asthma Phase 4 Terminated(safety concerns wit... More >>h pioglitazone) Less << - United Kingdom ... More >> Nottingham University Hospitals NHS Trust Nottingham, United Kingdom Less <<
NCT02338999 Systemic Lupus Erthematosus Phase 1 Phase 2 Recruiting June 18, 2020 United States, Maryland ... More >> National Institutes of Health Clinical Center, 9000 Rockville Pike Recruiting Bethesda, Maryland, United States, 20892 Contact: For more information at the NIH Clinical Center contact Office of Patient Recruitment (OPR) ?? 800-411-1222 ext TTY8664111010 ?? prpl@cc.nih.gov Less <<
NCT00459940 Growth Hormone Deficiency COMPLETED 2025-03-06 Medical Department M, The Medi... More >>cal Research Laboratories, Aarhus University Hospital, Aarhus C, 8000, Denmark Less <<
NCT02278562 ESRD Phase 2 Completed - United States, Tennessee ... More >> Tennessee Valley Healthcare System Nashville Campus, Nashville, TN Nashville, Tennessee, United States, 37212-2637 Less <<
NCT02694263 Diabetes Mellitus, Type 2 Phase 4 Recruiting September 2018 United Kingdom ... More >> University Hospitals of Leicester NHS Trust Recruiting Leicester, Leicestershire, United Kingdom, LE5 4PW Contact: Emer Brady, PhD ?? 0116248 ext 8959 ?? emer.brady@uhl-tr.nhs.uk ?? Contact: Natasha Wileman, MSc ?? 0116258 ext 8929 ?? natasha.wileman@uhl-tr.nhs.uk ?? University Hospitals Birmingham NHS Foundation Trust Recruiting Birmingham, West Midlands, United Kingdom, B15 2TH Contact: Wasim Hanif ?? 0121371 ext 4404 ?? wasim.hanif@uhb.nhs.uk ?? Contact: Deborah Smith ?? 0121371 ext 4707 ?? deborah.smith@uhb.nhs.uk Less <<
NCT00097279 Diabetes Diab... More >>etes Mellitus, Type 2 Less << Phase 3 Completed - -
NCT00285844 Insulin Resistance ... More >> Obesity Metabolic Syndrome Less << Phase 1 Completed - United States, California ... More >> Stanford University Stanford, California, United States, 94305 Less <<
NCT01025765 Chronic Hepatitis C Phase 4 Unknown December 2012 Taiwan ... More >> National Taiwan University Hospital Department of Internal Medicine, Taipei, Taiwan, 10002 Less <<
NCT02683226 Polycystic Ovary Syndrome ... More >> Insulin Resistance Less << Phase 4 Completed - Slovenia ... More >> University Medical Center Ljubljana Ljubljana, Slovenia, 1000 Less <<
NCT00308373 Diabetes Mellitus, Type 2 Not Applicable Completed - United States, Minnesota ... More >> Mayo Clinic Rochester, Minnesota, United States, 55905 Less <<
NCT02592317 Prostatic Neoplasms, Castratio... More >>n-Resistant Less << Phase 1 Active, not recruiting August 1, 2019 Moldova, Republic of ... More >> Chisinau, Moldova, Republic of Spain Barcelona, Spain Sevilla, Spain Less <<
NCT00543959 Diabetes Mellitus Type 2 Phase 2 Terminated(This study is being... More >> discontinued based on data suggesting that none of the doses tested demonstrated both glycemic & body fluid benefits vs. the comparitor) Less << - -
NCT02278562 - Completed - -
NCT01817400 Infertility, Female ... More >> Obesity Less << Early Phase 1 Completed - United States, Colorado ... More >> University of Colorado Denver Anschutz Medical Campus Aurora, Colorado, United States, 80045 Less <<
NCT00843791 Obesity Insul... More >>in Resistance Less << Not Applicable Completed - United States, Oregon ... More >> Oregon Health & Science University Portland, Oregon, United States, 97239 Less <<
NCT00806520 - Completed - United States, Massachusetts ... More >> Joslin Diabetes Center Boston, Massachusetts, United States, 02215 United States, Minnesota International Diabetes Center Minneapolis, Minnesota, United States, 55416 United States, Nevada Palm Medical Group Las Vegas, Nevada, United States, 89148 United States, North Carolina University of North Carolina Diabetes Care Center Durham, North Carolina, United States, 27713 United States, Washington Rockwood Clinic Spokane, Washington, United States, 99202 Less <<
NCT01489943 Crohn's Disease Phase 1 Completed - United States, New York ... More >> GSK Investigational Site Buffalo, New York, United States, 14202 Less <<
NCT02142309 Type 2 Diabetes Phase 4 Unknown January 2017 Italy ... More >> Department of Geriatrics and Metabolic Diseases Active, not recruiting Naples, Italy, 80138 Katherine Esposito Recruiting Naples, Italy, 80138 Contact: Maria Ida Maiorino, MD ?? ?? mariaida.maiorino@unina2.it ?? Sub-Investigator: Giuseppe Bellastella, MD Less <<
NCT00106704 - Completed - -
NCT00143520 Type 2 Diabetes Phase 2 Phase 3 Completed - -
NCT00106704 Diabetes Mellitus, Type 2 Phase 3 Completed - -
NCT01103414 Type 2 Diabetes Phase 2 Completed - United States, Alabama ... More >> Huntsville, Alabama, United States Muscle Shoals, Alabama, United States United States, California Chino, California, United States Los Angeles, California, United States Spring Valley, California, United States Walnut Creek, California, United States United States, Florida Miami, Florida, United States New Port Richley, Florida, United States Palm Harbor, Florida, United States Pembroke Pines, Florida, United States United States, Georgia Marietta, Georgia, United States United States, Illinois Chicago, Illinois, United States United States, Indiana Indianapolis, Indiana, United States United States, Michigan Grand Rapids, Michigan, United States United States, Ohio Cincinnati, Ohio, United States Kettering, Ohio, United States Tiffin, Ohio, United States United States, Oklahoma Oklahoma City, Oklahoma, United States United States, Oregon Eugene, Oregon, United States Portland, Oregon, United States United States, South Carolina Greer, South Carolina, United States United States, Texas Corpus Christi, Texas, United States Houston, Texas, United States San Antonio, Texas, United States Less <<
NCT00926341 Metabolic Syndrome Phase 4 Completed - India ... More >> Department of Medicine, J.N.Medical,College, AMU,Aligarh Aligarh, Uttar Pradesh, India, 202002 Less <<
NCT00155350 Coronary Atherosclerosis ... More >> Inflammation Coronary Heart Disease Less << Phase 4 Unknown - Taiwan ... More >> Division of Cardiology, Department of Internal Medicine and Department of Medical Imaging, National Taiwan University Hospital Recruiting Taipei, Taiwan, 100 Contact: Tzung-Dau Wang, MD, PhD ?? 886-2-2312-3456 ext 5632 ?? tdwang@ha.mc.ntu.edu.tw ?? Principal Investigator: Tzung-Dau Wang, MD, PhD ?? ?? ?? Sub-Investigator: Wen-Jeng Lee, MD Less <<
NCT01076075 Type 2 Diabetes Mellitus Phase 3 Completed - -
NCT01002547 Nonalcoholic Steatohepatitis Phase 4 Completed - United States, Florida ... More >> North Florida/South Georgia Veterans Health System, Gainesville, FL Gainesville, Florida, United States, 32608 United States, Texas South Texas Health Care System, San Antonio, TX San Antonio, Texas, United States, 78229 Less <<
NCT00232583 - Completed - -
NCT01103414 - Completed - -
NCT00443755 Type 2 Diabetes ... More >> Insulin Resistance Metabolic Syndrome Less << Phase 2 Completed - United States, Minnesota ... More >> Mayo Clinic Rochester, Minnesota, United States, 55905 Less <<
NCT00232583 Type 2 Diabetes Mellitus Not Applicable Completed - United States, Texas ... More >> University of Texas Southwestern Dallas, Texas, United States, 75390 Less <<
NCT02653209 Type 2 Diabetes Phase 4 Recruiting December 2019 United Kingdom ... More >> Exeter Clinical Research Facility Recruiting Exeter, United Kingdom, EX2 5DW Contact: Catherine Angwin ?? 01392408185 ?? C.Angwin@exeter.ac.uk ?? Contact: Andrew Hattersley ?? +441392 408231 ?? A.T.Hattersley@exeter.ac.uk ?? Principal Investigator: Andrew Hattersley Less <<
NCT01076075 - Completed - -
NCT00443755 - Completed - -
NCT01174056 Lung Inflammation Early Phase 1 Completed - United States, Missouri ... More >> Washington University / Barnes Jewish Hospital St. Louis, Missouri, United States, 63110 Less <<
NCT00362440 HIV Lipodystrophy Phase 2 Completed - United States, Massachusetts ... More >> Beth Israel Deaconess Medical Center Boston, Massachusetts, United States, 02215 Less <<
NCT00362440 - Completed - -
NCT00153166 - Completed - -
NCT01026194 - Completed - -
NCT00780715 Diabetes Mellitus, Type 2 Phase 4 Completed - United Kingdom ... More >> Ninewells Hospital & Medical School Dundee, United Kingdom, DD1 9SY Less <<
NCT00153166 Arterial Occlusive Disease ... More >> Intermittent Claudication Insulin Resistance Less << Phase 2 Phase 3 Completed - United States, Massachusetts ... More >> Brigham & Women's Hospital Boston, Massachusetts, United States, 02115 Less <<
NCT01002547 - Completed - -
NCT00780715 - Completed - -
NCT00849056 Diabetes Mellitus, Type 2 Phase 3 Completed - -
NCT01026194 Type 2 Diabetes Mellitus Phase 3 Completed - Japan ... More >> Shinjukuku, Tokyo, Japan Less <<
NCT00849056 - Completed - -
NCT00637273 Type 2 Diabetes Mellitus Phase 3 Completed - -
NCT01089790 Diabetes Mellitus, Type 2 Phase 3 Terminated - -
NCT00637273 - Completed - -
NCT02787551 Type 2 Diabetes Mellitus Phase 3 Active, not recruiting November 20, 2018 -
NCT00575874 Type 2 Diabetes Phase 2 Completed - China ... More >> Hong Kong, China Less <<
NCT00846716 Type 2 Diabetes Mellitus Not Applicable Unknown November 2011 Japan ... More >> Shiga University of Medical Science Recruiting Otsu, Shiga, Japan, 520-2192 Contact: Hiroshi Maegawa, PhD ?? +81-77-548-2222 ?? maegawa@belle.shiga-med.ac.jp ?? Contact: Takashi Uzu, PhD ?? +81-77-548-2222 ?? tuzu@belle.shiga-med.ac.jp ?? Principal Investigator: Yoshihiko Nishio, PhD ?? ?? ?? Principal Investigator: Takashi Uzu, PhD ?? ?? ?? Principal Investigator: Masato Ohji, PhD ?? ?? ?? Sub-Investigator: Osamu Sawada, PhD ?? ?? ?? Principal Investigator: Daisuke Koya, PhD Less <<
NCT02767063 Leukemia, Myeloid, Chronic-Pha... More >>se Less << Phase 1 Phase 2 Recruiting June 2021 France ... More >> Martine GARDEMBAS Recruiting Angers, France Contact: Martine GARDEMBAS ?? 02.41.35.44.75 ?? MaGardembas@chu-angers.fr ?? Pascale CONY.MAKHOUL Recruiting Annecy, France Contact: Pascale CONY.MAKHOUL ?? 04.50.63.64.31 ?? pconymakhoul@ch-annecygenevois.fr ?? Thorsten BRAUN Recruiting Bobigny, France Contact: Thorsten BRAUN ?? 01.48.95.54.58 ?? Thorsten.braun@avc.aphp.fr ?? Etienne Recruiting Bordeaux, France Contact: Gabriel Etienne ?? 05.56.33.04.76 ?? G.Etienne@bordeaux.unicancer.fr ?? CHU C?te de Nacre Not yet recruiting Caen, France Contact: Hyacynthe Johnson-Ansah ?? 02.31.27.25.39 ?? Johnsonansah-a@chu-caen.fr ?? CHU Estaing Not yet recruiting Clermont-Ferrand, France Contact: Marc BERGER ?? ?? mberger@chu-clermontferrand.fr ?? CH Henri Mondor Recruiting Créteil, France Contact: ROY Lydia ?? ?? ?? Rousselot Recruiting Le Chesnay, France Contact: Philippe Rousselot ?? 01.39.63.89.09 ?? phrousselot@ch-versailles.fr ?? CHU Lille Recruiting Lille, France Contact: COITEUX Valérie ?? ?? ?? CHU de LIMOGES Not yet recruiting Limoges, France Contact: Amélie PENOT ?? 05.55.05.66.42 ?? Amelie.penot@chu-limoges.fr ?? Franck NICOLINI Recruiting Lyon, France Contact: Franck NICOLINI ?? 04.72.11.74.01 ?? franck.nicolini@chu-lyon.fr ?? Institut P Calmette Recruiting Marseille, France Contact: CHARBONNIER Aude ?? ?? ?? Viviane DUBRUILLE Recruiting Nantes, France Contact: Viviane DUBRUILLE ?? 02.40.08.32.71 ?? Viviane.dubruille@chu-nantes.fr ?? Hopital l'Archet Not yet recruiting Nice, France Contact: Laurence LEGROS ?? 04.92.03.58.41 ?? legros.l@chu-nice.fr ?? Eric JOURDAN Recruiting Nimes, France Contact: Eric JOURDAN ?? 04.66.68.32.31 ?? eric.jourdan@chu-nimes.fr ?? H?pital La Source Recruiting Orléans, France Contact: BENBRAHIM Omar ?? ?? ?? Delphine REA _St louis Recruiting Paris, France Contact: Delphine REA ?? 01.42.49.96.49 ?? delphine.rea@aphp.fr ?? Simona LAPUSAN_St Antoine Recruiting Paris, France Contact: Simona LAPUSAN ?? 01.49.28.34.42 ?? Simona.lapusan@sat.aphp.fr ?? Cayssials Recruiting Poitiers, France Contact: Emilie Cayssials ?? : 05.49.44. 44.72 ?? e.cayssials@chu-poitiers.fr ?? CHU de Rennes - Pontchaillou Recruiting Rennes, France Contact: ESCOFFRE-BARBE Martine ?? ?? ?? H?pital René Huguenin Not yet recruiting Saint-Cloud, France Contact: Sylvie GLAISNER ?? 01.47.11.15.30 ?? Sylvie.glaisner@curie.net ?? Institut Universitaire contre le Cancer Not yet recruiting Toulouse, France Contact: Fran?oise HUGUET ?? 05.31.15.63.56 ?? Huguet.fran?oise@iuct-oncopole.fr ?? CHU Tours Not yet recruiting Tours, France Contact: DARTIGEAS Caroline Less <<
NCT01471808 Diabetes Mellitus, Type 2 Phase 4 Enrolling by invitation December 2021 -
NCT01064687 - Completed - -
NCT01147627 Diabetes Mellitus, Type 2 ... More >> Newly Diagnosed Less << Not Applicable Completed - -
NCT00839527 Diabetes Mellitus, Type 2 Phase 3 Completed - -
NCT01911728 Pharmacokinetics of MDV3100 ... More >> Castration Resistant Prostate Cancer (CRPC) Less << Phase 1 Completed - South Africa ... More >> Parexel George, South Africa Parexel/Qdot Pharma Port Elizabeth, South Africa Less <<
NCT01064687 Diabetes Mellitus, Type 2 Phase 3 Completed - -
NCT02305069 Obesity Sarco... More >>penia Less << Not Applicable Completed - United Kingdom ... More >> David Greenfield Physiology Laboratories Nottingham, Nottinghamshire, United Kingdom, NG7 2UH Less <<
NCT00189774 Type 2 Diabetes Mellitus ... More >> Diabetes Mellitus, Type II Less << Phase 2 Phase 3 Completed - Japan ... More >> Chubu region, Japan Chugoku region, Japan Hokkaido region, Japan Kanto region, Japan Kinki region, Japan Kyushu region, Japan Tohoku region, Japan Less <<
NCT00196989 Diabetes Mellitus, Type 2 Phase 2 Completed - -
NCT00229684 Diabetes Mellitus, Type 2 Phase 2 Terminated(The development pro... More >>gram has been terminated) Less << - United States, California ... More >> Research Site Pasadena, California, United States United States, District of Columbia Research Site Washington, District of Columbia, United States United States, Florida Research Site Gainesville, Florida, United States Research Site Miami, Florida, United States Research Site Orlando, Florida, United States United States, Georgia Research Site Augusta, Georgia, United States Research Site Columbus, Georgia, United States United States, Louisiana Research Site New Orleans, Louisiana, United States United States, Nevada Research Site Reno, Nevada, United States United States, New York Research Site Flushing, New York, United States United States, North Carolina Research Site Durham, North Carolina, United States United States, Ohio Research Site Cleveland, Ohio, United States Research Site Columbus, Ohio, United States United States, Oklahoma Research Site Tulsa, Oklahoma, United States United States, Pennsylvania Research Site Cheswick, Pennsylvania, United States Research Site Philadelphia, Pennsylvania, United States United States, Tennessee Research Site Nashville, Tennessee, United States United States, Texas Research Site Midland, Texas, United States Research Site San Antonio, Texas, United States United States, Washington Research Site Gig Harbor, Washington, United States Research Site Seattle, Washington, United States Less <<
NCT01147627 - Completed - -
NCT00368017 Chronic Kidney Disease Phase 2 Terminated(unable to replace F... More >>ellow conducting the study who left institution in 2007) Less << - United States, Tennessee ... More >> Vanderbilt University Medical Center Nashville, Tennessee, United States, 37232 Less <<
NCT00484198 Type 2 Diabetes Mellitus Phase 3 Completed - -
NCT01748994 Obesity Metab... More >>olic Syndrome Less << Not Applicable Completed - United States, Louisiana ... More >> Pennington Biomedical Research Center Baton Rouge, Louisiana, United States, 70808 Pennington Biomedical Research Center Baton Rouge, Louisiana, United States, 70809 Less <<
NCT00839527 - Completed - -
NCT00548158 - Completed - -
NCT01230749 - Completed - -
NCT00736099 Diabetes Mellitus, Type 2 Phase 3 Completed - -
NCT00736099 - Completed - -
NCT00515632 Diabetes Mellitus, Type 2 Phase 3 Completed - Denmark ... More >> Multi-center Copenhagen, Denmark Less <<
NCT00743327 Hypogonadism|Metabolic Syndrom... More >>e|Diabetes|Inflammation Less << TERMINATED 2025-08-12 NIA Clinical Research Unit loc... More >>ated at Harbor Hospital, Baltimore, Maryland, 21225, United States Less <<
NCT02535832 Rheumatoid Arthritis ... More >> Insulin Resistance Less << Phase 1 Recruiting July 2020 United States, Alabama ... More >> University of Alabama at Birmingham Recruiting Birmingham, Alabama, United States, 35294 Contact: Beatriz Hanaoka, MD ?? 205-996-0843 ?? bhanaoka@uabmc.edu ?? Contact: Laura E Tudor ?? 205-934-4021 ?? ltudor@uabmc.edu Less <<
NCT00437970 Diabetes Mellitus, Type 2 Phase 4 Withdrawn(Unable to secure sup... More >>ply of the study medication) Less << February 2009 Australia, Northern Territory ... More >> Menzies School of Health Research Darwin, Northern Territory, Australia, 0810 Less <<
NCT02365233 Type II Diabetes ... More >> Nonalcoholic Fatty Liver Less << Phase 4 Terminated(IRB withheld the da... More >>ta due to inadequate supporting documentation) Less << - United States, Texas ... More >> University of Texas Medical Branch -Galveston Galveston, Texas, United States, 77555 Less <<
NCT02365233 - Terminated(IRB withheld the da... More >>ta due to inadequate supporting documentation) Less << - -
NCT01230749 Diabetes Mellitus, Type 2 Phase 2 Completed - -
NCT00745914 Endstage Renal Disease ... More >> Diabetes Less << Not Applicable Completed - Hong Kong ... More >> Queen Mary Hospital and Tung Wah Hospital Hong Kong, Hong Kong, 0000 Queen Mary Hospital, Tung Wah Hospital Hong Kong, Hong Kong, 0000 Less <<
NCT00972283 Diabetes Diab... More >>etes Mellitus, Type 2 Less << Phase 3 Completed - -
NCT01289639 Fatty Liver Not Applicable Terminated(Low recruitment in ... More >>intervention study. Baseline data published.) Less << - United States, Washington ... More >> VA Puget Sound Health Care System, Seattle Seattle, Washington, United States, 98108 Less <<
NCT00892372 - Completed - Japan ... More >> Department of Diabetes and Endocrinology, Saitama Medical Center, Saitama Medical University Kawagoe, Saitama, Japan, 350-8550 Less <<
NCT00972283 - Completed - -
NCT00411892 Diabetes Diab... More >>etes Mellitus, Type 2 Less << Phase 3 Terminated(See termination rea... More >>son in detailed description) Less << - -
NCT00377975 Obesity Phase 2 Completed - United States, Louisiana ... More >> Pennington Biomedical Research Center Baton Rouge, Louisiana, United States, 70808 Less <<
NCT01289119 Diabetes Mellitus, Type 2 Phase 3 Completed - -
NCT00745225 End-stage Renal Disease Phase 4 Completed - Hong Kong ... More >> Queen Mary Hospital, Tung Wah Hospital, Pamela Youde Nethersole Eastern Hospital Hong Kong, Hong Kong, 0000 Less <<
NCT01339143 Diabetes Mellitus ... More >> Oxidative Stress Less << Phase 4 Unknown May 2013 Korea, Republic of ... More >> Korea University Anam Hospital Recruiting Seoul, Korea, Republic of Less <<
NCT01289639 - Terminated(Low recruitment in ... More >>intervention study. Baseline data published.) Less << - -
NCT01318070 Type 2 Diabetes Mellitus Phase 2 Phase 3 Completed - -
NCT01289119 - Completed - -
NCT00179400 Type 2 Diabetes Mellitus Not Applicable Completed - United States, New York ... More >> Albert Einstein College of Medicine The Bronx, New York, United States, 10461 Less <<
NCT03030300 Type2 Diabetes Phase 4 Completed - China, Shandong ... More >> Shandong Provincial Hospital Jinan, Shandong, China, 250001 Qianfoshan Hospital Jinan, Shandong, China, 250012 Qilu Hospital Jinan, Shandong, China, 250014 Less <<
NCT00237237 Diabetes Mellitus, Type 2 Phase 3 Completed - United States, New Jersey ... More >> Novartis Pharmaceuticals East Hanover, New Jersey, United States, 07936 Germany Investigative Centers Nurnberg, Germany Less <<
NCT00402909 Type 2 Diabetes Phase 4 Completed - United States, New Jersey ... More >> Novartis Pharmaceuticals East Hanover, New Jersey, United States, 07974 Less <<
NCT00101803 Diabetes Mellitus, Type 2 Phase 3 Completed - United States, New Jersey ... More >> Novartis Pharmaceuticals East Hanover, New Jersey, United States, 07936 Less <<
NCT00242177 Multiple Sclerosis, Relapsing-... More >>Remitting Less << Phase 1 Completed - United States, Illinois ... More >> University of Illinois at Chicago Chicago, Illinois, United States, 60612 Less <<
NCT03298464 Obese Phase 1 Recruiting December 2018 United States, California ... More >> Prosciento Recruiting Chula Vista, California, United States, 91911 Contact: Prosciento Recruitment ?? 866-308-7427 ?? volunteer@prosciento.com Less <<
NCT00996658 - Completed - -
NCT03646292 NAFLD - Nonalcoholic Fatty Liv... More >>er Disease Type2 Diabetes Less << Phase 4 Not yet recruiting March 2021 Korea, Republic of ... More >> Yonsei University College of Medicine, Department of Internal Medicine, Division of Endocrinology, Severance Hospital, Diabetes Center Not yet recruiting Seoul, Korea, Republic of, 03722 Contact: Bong Soo Cha, MD ?? +82-2-2228-1932 ?? bscha@yuhs.ac Less <<
NCT00091949 Stroke Myocar... More >>dial Infarction Diabetes Less << Phase 3 Completed - -
NCT00996658 Diabetes Mellitus, Type 2 Phase 3 Completed - -
NCT00427999 - Completed - -
NCT00297063 Diabetes Mellitus, Type 2 Phase 3 Completed - Japan ... More >> GSK Investigational Site Hokkaido, Japan, 051-0005 GSK Investigational Site Ibaraki, Japan, 311-0113 GSK Investigational Site Kanagawa, Japan, 224-0024 GSK Investigational Site Tokyo, Japan, 125-0054 GSK Investigational Site Tokyo, Japan, 130-0004 Less <<
NCT00091949 - Completed - -
NCT00108615 Glucose Metabolism Disorders ... More >> Diabetes Less << Phase 4 Completed - United States, Arkansas ... More >> Central Arkansas Veterans HCS Little Rock, Arkansas, United States, 72205 Less <<
NCT00427999 Prostate Cancer Phase 2 Completed - Germany ... More >> Novartis Investigative Site Bad Reichenhall, Germany, 83435 Novartis Investigative Site Bonn, Germany, 53105 Novartis Investigative Site Hamburg, Germany, 20246 Novartis Investigative Site Hamburg, Germany, 22607 Novartis Investigative Site Kassel, Germany, 34131 Novartis Investigative Site Markkleeberg, Germany, 04416 Novartis Investigative Site Passau, Germany, 94032 Novartis Investigative Site Planegg, Germany, 82152 Novartis Investigative Site Regensburg, Germany, 93053 Novartis Investigative Site Tübingen, Germany, 72076 Less <<
NCT00214565 Diabetes Mellitus, Type 2 Phase 3 Terminated(The development pro... More >>gram has been terminated) Less << - -
NCT01010243 Multiple Myeloma Phase 1 Phase 2 Unknown October 2016 Germany ... More >> Sch?n Klinik Starnberger See Recruiting Berg, Germany, 82335 Contact: Christian Straka, PD MD ?? ?? ?? Principal Investigator: Christian Straka, PD MD ?? ?? ?? Gemeinschaftspraxis Dres. med. J. Wilke u. H. Wagner Recruiting Fürth, Germany, 90766 Contact: Jochen Wilke, MD ?? ?? ?? Principal Investigator: Jochen Wilke, MD ?? ?? ?? Universit?tsklinikum Schleswig-Holstein, II Medizin, Sekt. f. Stammzell- u. Immuntherapie Recruiting Kiel, Germany, 24105 Contact: Martin Gramatzki, Prof. MD ?? ?? ?? Principal Investigator: Martin Gramatzki, Prof. MD ?? ?? ?? Klinikum d. Universit?t München, Med. Klinik u. Poliklinik IV, Abt. H/O Recruiting München, Germany, 80336 Contact: Christian Adam, MD ?? ?? ?? Principal Investigator: Christian Adam, MD ?? ?? ?? Gemeinschaftspraxis H?mato/Onkologie Recruiting München, Germany, 81241 Contact: Burkhard Schmidt, MD ?? ?? ?? Principal Investigator: Burkhard Schmidt, MD ?? ?? ?? University of Regensburg Recruiting Regensburg, Germany, 93053 Contact: Albrecht Reichle, Professor ?? ?? albrecht.reichle@klinik.uni-regensburg.de ?? Sub-Investigator: Matthias Grube, MD ?? ?? ?? Sub-Investigator: Joachim Hahn, MD ?? ?? ?? Sub-Investigator: Stephanie Mayer, MD ?? ?? ?? Sub-Investigator: Martin Vogelhuber, MD ?? ?? ?? Sub-Investigator: Christina Hart, MD ?? ?? ?? Sub-Investigator: Karin Landfried, MD ?? ?? ?? Sub-Investigator: Marco Petronio, MD ?? ?? ?? Sub-Investigator: Dagmar Roll, MD ?? ?? ?? Sub-Investigator: Tanja Zilch, MD Less <<
NCT01318070 - Completed - -
NCT01454336 Liver Fibrosis Phase 1 Completed - Iran, Islamic Republic of ... More >> Royan Institute Tehran, Iran, Islamic Republic of Less <<
NCT01318122 - Completed - -
NCT02774343 Cocaine Use Disorder ... More >> Alcohol Use Disorder Less << Phase 1 Phase 2 Completed - United States, Texas ... More >> The University of Texas Health Science Center at Houston Houston, Texas, United States, 77030 Less <<
NCT01686711 Diabetes Mellitus Phase 4 Completed - Japan ... More >> Hirosaki-shi, Aomori, Japan Kisaratsu-shi, Chiba, Japan Matsuyama-shi, Ehime, Japan Fukuoka-shi, Fukuoka, Japan Kitakyushu-shi, Fukuoka, Japan Kurume-shi, Fukuoka, Japan Fukuyama-shi, Hiroshima, Japan Hiroshima-shi, Hiroshima, Japan Sapporo-shi, Hokkaido, Japan Koga-shi, Ibaraki, Japan Yokohama-shi, Kanagawa, Japan Kumamoto-shi, Kumamoto, Japan Miyazaki-shi, Miyazaki, Japan Suita-shi, Osaka, Japan Koshigaya-shi, Saitama, Japan Otsu-shi, Shiga, Japan Chiyoda-ku, Tokyo, Japan Chuo-ku, Tokyo, Japan Itabashi-ku, Tokyo, Japan Meguro-ku, Tokyo, Japan Minato-ku, Tokyo, Japan Ohta-ku, Tokyo, Japan Shinjuku-ku, Tokyo, Japan Toyama-shi, Toyama, Japan Shimonoseki-shi, Yamaguchi, Japan Less <<
NCT01318122 Type 2 Diabetes Mellitus Phase 2 Phase 3 Completed - -
NCT00586261 Chronic Kidney Disease Not Applicable Terminated(Low enrollment beca... More >>use of the specifics of the inclusion criteria) Less << - United States, Minnesota ... More >> Mayo Clinic Rochester, Minnesota, United States, 55905 Less <<
NCT00737347 Type 2 Diabetes ... More >> Obesity Less << Phase 3 Completed - United States, Illinois ... More >> Northwestern Memorial Hospital Wellness Institute Chicago, Illinois, United States, 60611 Less <<
NCT03452267 Insulin Sensitivity Phase 2 Phase 3 Not yet recruiting June 2020 -
NCT01210001 Diabetes Mellitus, Type 2 Phase 3 Completed - -
NCT00586261 - Terminated(Low enrollment beca... More >>use of the specifics of the inclusion criteria) Less << - -
NCT02774343 - Completed - -
NCT02341703 Polycystic Ovary Syndrome ... More >> Infertility Less << Early Phase 1 Completed - Egypt ... More >> faculty of medicine, Cairo University Cairo, Egypt, 002 Less <<
NCT01210001 - Completed - -
NCT01206647 Diabetes Mellitus, Type 2 Phase 4 Unknown February 2011 Germany ... More >> Diabetologische Schwerpunktpraxis Dr. Lorra / Dr. Bonnermann Bochum, Germany, 44869 Zentrum für klinische Studien Dresden, GWT-TUD GmbH Dresden, Germany, 01307 Gemeinschaftspraxis Partner der Gesundheit Essen, Germany, 45355 IKFE Institute for Clinical Research and Development Mainz, Germany, 55116 Zentrum für Diabetes und Gef??erkrankungen Münster, Germany, 48145 Diabetes Zentrum Neuwied Neuwied, Germany, 56564 ikfe Studiencenter Potsdam GmbH Potsdam, Germany, 14469 Less <<
NCT03492580 - Completed - United States, New Jersey ... More >> Janssen Investigative Site Titusville, New Jersey, United States, 08560 Less <<
NCT01774968 Diabetes Mellitus, Type 2 Phase 4 Completed - -
NCT01774968 - Completed - -
NCT01974544 Type 2 Diabetes Not Applicable Unknown December 2016 Chile ... More >> Pontificia Universidad Católica de Chile Recruiting Santiago, Región Metropolitana, Chile, 8330033 Contact: Castillo Alejandra, Nurse ?? 56223543527 ?? macastia@uc.cl ?? Contact: Vega Andrea, Nurse ?? 56223543879 ?? abvega@uc.cl ?? Principal Investigator: Boza Camilo, MD surgeon ?? ?? ?? Sub-Investigator: Valderas Juan Patricio, MD ?? ?? ?? Sub-Investigator: Arrese Marco, MD Internist ?? ?? ?? Sub-Investigator: Mu?oz Rodrigo, MD Less <<
NCT00975286 - Completed - -
NCT00975286 Type 2 Diabetes Mellitus Phase 3 Completed - -
NCT02476760 - Completed - Canada, Quebec ... More >> Lady Davis Institute for Medical Research, Jewish General Hospital Montreal, Quebec, Canada, H3T1E2 Less <<
NCT02815891 - Recruiting July 2021 -
NCT00000620 Atherosclerosis ... More >> Cardiovascular Diseases Hypercholesterolemia Hypertension Diabetes Mellitus, Type 2 Diabetes Mellitus Coronary Disease Less << Phase 3 Completed - United States, Minnesota ... More >> Minneapolis Medical Research Foundation Minneapolis, Minnesota, United States, 55404 United States, New York Columbia University New York, New York, United States, 10027 United States, North Carolina Wake Forest University Winston-Salem, North Carolina, United States, 27106 United States, Ohio Case Western Reserve University Cleveland, Ohio, United States, 44106 United States, Tennessee Veterans Affairs Memphis, Tennessee, United States, 38104 United States, Washington University of Washington Seattle, Washington, United States, 98195 Canada, Ontario McMaster University Hamilton, Ontario, Canada Less <<
NCT01798706 Type 2 Diabetes Phase 3 Completed - -
NCT00000620 - Completed - -
NCT02475499 - Completed - Canada, Quebec ... More >> Lady Davis Institute for Medical Research, Jewish General Hospital Montreal, Quebec, Canada, H3T1E2 Less <<
NCT02616666 Type 2 Diabetes Mellitus Phase 4 Recruiting December 31, 2021 -
NCT01289990 Diabetes Mellitus, Type 2 Phase 3 Completed - -
NCT01289990 - Completed - -
NCT02503865 Metabolic Syndrome Phase 1 Phase 2 Completed - Kazakhstan ... More >> Republican Scientific Center for Emergency Medicine Astana, Kazakhstan, 010000 Less <<
NCT01759823 Type 2 Diabetes Mellitus Phase 2 Phase 3 Completed - India ... More >> Postgraduate Institute of Medical Education and Research Chandigarh, UT, India, 160012 Less <<
NCT01038011 Ankylosing Spondylitis Phase 2 Completed - Switzerland ... More >> Zurich, Switzerland Less <<
NCT01798706 - Completed - -
NCT02503865 - Completed - -
NCT01697592 Type 2 Diabetes Mellitus Phase 3 Completed - -
NCT01697592 - Completed - -
NCT00133718 Type 2 Diabetes Mellitus Phase 4 Completed - Norway ... More >> Asker and Baerum Hospital, Medical Department RUD, Norway, 1309 Less <<
NCT02456428 - Completed - Canada, Quebec ... More >> Lady Davis Institute for Medical Research, Jewish General Hospital Montreal, Quebec, Canada, H3T1E2 Less <<
NCT01065298 - Completed - India ... More >> Post Graduate Institute of Medical Education and Research Chandigarh, Chandigarh UT, India Less <<
NCT01162772 - Unknown - Austria ... More >> Medical University of Viemma Recruiting Vienna, Austria, 1090 Contact: Jeanette Strametz-Juranek, MD ?? 0043140400 ext 4618 ?? jeanette.strametz-juranek@meduniwien.ac.at ?? Contact: Alexandra Kautzky-Willer, MD ?? 0140400 ext 4316 ?? alexandra.kautzky-willer@meduniwien.ac.at ?? Principal Investigator: Jeanette Strametz-Juranek, MD ?? ?? ?? Principal Investigator: Alexandra Kautzky-Willer, MD ?? ?? ?? Sub-Investigator: Alia Sabri, MD ?? ?? ?? Sub-Investigator: Lana Kosi, MD Less <<
NCT03335956 Healthy Phase 1 Completed - United Kingdom ... More >> Hammersmith Medicines Research London, United Kingdom Less <<
NCT00732121 Type 2 Diabetes Phase 4 Unknown August 2010 United States, Vermont ... More >> University of Vermont South Burlington, Vermont, United States, 05403 Less <<
NCT00481663 Type II Diabetes Mellitus Phase 2 Completed - -
NCT01919489 Type 2 Diabetes Phase 4 Recruiting June 2019 United States, Florida ... More >> University of Miami Recruiting Miami, Florida, United States Contact: Gianluca Iacobellis, MD ?? ?? GIacobellis@med.miami.edu ?? Principal Investigator: Gianluca Iacobellis, MD ?? ?? ?? United States, Georgia Grady Memorial Hospital Recruiting Atlanta, Georgia, United States, 30303 Contact: Guillermo E Umpierrez, MD ?? 404-778-1665 ?? geumpie@emory.edu ?? Contact: Francisco J Pasquel, MD ?? 404 778 1697 ?? fpasque@emory.edu ?? Principal Investigator: Guillermo Umpierrez, MD ?? ?? ?? Sub-Investigator: Francisco J Pasquel, MD ?? ?? ?? Sub-Investigator: Priya Vellanki, MD ?? ?? ?? Emory University Hospital Recruiting Atlanta, Georgia, United States, 30324 Contact: Francisco Pasquel, MD ?? ?? fpasque@emory.edu ?? Sub-Investigator: Francisco Pasquel, MD ?? ?? ?? Emory Universtiy Hospital at MIdtown Recruiting Atlanta, Georgia, United States Contact: Francisco Pasquel, MD ?? ?? ?? Sub-Investigator: Rodolfo J Galindo, MD ?? ?? ?? United States, New York State University of NY at Buffalo Recruiting New York, New York, United States Contact: Ajay Chaudhuri, MD ?? ?? AChaudhuri@KaleidaHealth.Org ?? Principal Investigator: Ajay Chaudhuri, MD Less <<
NCT02298192 - Completed - -
NCT02778776 Metabolic Syndrome Phase 3 Completed - Mexico ... More >> Universidad de Guadalajara Guadalajara, Jalisco, México, Mexico, 44100 Less <<
NCT01039532 - Completed - India ... More >> AnilBhansali Chandigarh, India, 160012 Less <<
NCT00214253 Type 1 Diabetes Phase 1 Completed - United States, Wisconsin ... More >> University of Wisconsin Madison, Wisconsin, United States, 53792 Less <<
NCT02298192 Diabetes Diab... More >>etes Mellitus, Type 2 Less << Phase 3 Completed - -
NCT00673309 Burns Phase 2 Phase 3 Completed - United States, Texas ... More >> University of Texas Medical Branch Galveston, Texas, United States, 77550 Less <<
NCT00598793 Diabetes Diab... More >>etes Mellitus, Type 2 Less << Phase 3 Completed - -
NCT02773927 Metabolic Syndrome Phase 3 Completed - Mexico ... More >> Universidad de Guadalajara Guadalajara, Jalisco, México, Mexico, 44100 Less <<
NCT00964106 Drug Interactions Phase 1 Completed - Korea, Republic of ... More >> GSK Investigational Site Busan, Korea, Republic of, 614-735 GSK Investigational Site Seoul, Korea, Republic of, 110-744 Less <<
NCT01336023 Diabetes Diab... More >>etes Mellitus, Type 2 Less << Phase 3 Completed - -
NCT01336023 - Completed - -
NCT00015626 Insulin Resistance ... More >> Diabetes Mellitus Less << Phase 2 Completed - United States, New York ... More >> Cornell University New York, New York, United States, 10021 Less <<
NCT02695121 - Recruiting April 30, 2024 United States, Delaware ... More >> Research Site Recruiting Wilmington, Delaware, United States United States, District of Columbia Research Site Recruiting Washington, District of Columbia, United States Netherlands Research Site Recruiting Utrecht, Netherlands United Kingdom Research Site Recruiting London, United Kingdom Less <<
NCT00357370 - Completed - -
NCT01046110 Diabetes Diab... More >>etes Mellitus, Type 2 Less << Phase 3 Completed - -
NCT00357370 Type 2 Diabetes Phase 2 Phase 3 Completed - -
NCT01046110 - Completed - -
NCT01095666 - Completed - -
NCT01095666 Type 2 Diabetes Phase 3 Completed - -
NCT00543556 Type 2 Diabetes Mellitus Phase 2 Terminated - -
NCT00683878 Type 2 Diabetes Phase 3 Completed - -
NCT02072096 - Terminated(The trial was termi... More >>nated per protocol because of lack of feasibility.) Less << - -
NCT02072096 Diabetes Mellitus, Type 2 Phase 4 Terminated(The trial was termi... More >>nated per protocol because of lack of feasibility.) Less << - -
NCT01055223 - Completed - -
NCT00683878 - Completed - -
NCT01055223 - Completed - -
NCT00295633 Diabetes Mellitus, Type 2 Phase 3 Completed - -
NCT00680745 Type 2 Diabetes Phase 3 Completed - -
NCT00676338 Type 2 Diabetes Mellitus Phase 3 Completed - -
NCT02285205 Type 2 Diabetes ... More >> Non-alcoholic Fatty Liver Disease Less << Phase 4 Completed - Korea, Republic of ... More >> Severance Hospital, Department of Internal Medicine, Yonsei University College of Medicine Seoul, Korea, Republic of, 120-752 Less <<
NCT00676338 - Completed - -
NCT00765817 Type 2 Diabetes Phase 3 Completed - -
NCT00547274 Diabetes Mellitus, Type II ... More >> Dyslipidemia Less << Phase 3 Terminated - -
NCT00680745 - Completed - -
NCT00327015 Diabetes Phase 3 Completed - -
NCT00765817 - Completed - -
NCT00327015 - Completed - -
NCT00121667 Diabetes Mellitus, Type 2 Phase 3 Completed - -
NCT00295633 - Completed - -
NCT02879409 Diabetes Mellitus Type 2 Not Applicable Recruiting August 2019 Qatar ... More >> Hamad Medical Corporation Recruiting Doha, Qatar, 3050 Contact: Ibrahim Janahi, MD ?? 4439-2434 ext 00974 ?? Imohd@hamad.qa ?? Principal Investigator: Ibrahim Janahi, MD ?? ?? ?? Sub-Investigator: Mashhood Siddique, MD ?? ?? ?? Sub-Investigator: Hamda Ali, MD Less <<
NCT00121667 - Completed - -
NCT02292290 Type 2 Diabetes Phase 4 Completed - United Kingdom ... More >> University Hospitals of Leicester Leicester, Leicestershire, United Kingdom University Hospital Birmingham Birmingham, West Midlands, United Kingdom Less <<
NCT00290940 Diabetes Mellitus, Type 2 Phase 2 Completed - -
NCT00396227 Diabetes Mellitus, Type 2 Phase 3 Completed - United States, New Jersey ... More >> Novartis Pharmaceuticals East Hanover, New Jersey, United States, 07936 Less <<
NCT00353587 Type 2 Diabetes Phase 2 Phase 3 Completed - -
NCT01087567 Type 2 Diabetes Phase 4 Completed - United States, Ohio ... More >> Ohio University Athens, Ohio, United States, 45701 Less <<
NCT01217073 Type 2 Diabetes Mellitus Phase 2 Completed - -
NCT00814372 Type 2 Diabetes Mellitus Phase 2 Terminated(MBX-102 did not mee... More >>t the target efficacy profile of HbA1c change.) Less << - United States, California ... More >> Providence Clinical Research Burbank, California, United States, 91505 American Institute of Research Los Angeles, California, United States, 90017 United States, Nevada Nevada Alliance Against Diabetes Las Vegas, Nevada, United States, 89101 United States, North Carolina Piedmont Medical Research Associates Winston-Salem, North Carolina, United States, 27103 United States, Texas DGD Research, Inc. San Antonio, Texas, United States, 78229 India Kamineni Hospitals Pvt, Ltd. Hyderabad, Andhra Pradesh, India, 50008 Bangalore Diabetes Centre Bangalore, India Diacon Hospital Diabetes & Research Centre Bangalore, India M. S. Ramaiah Memorial Hospital Bangalore, India St. John's Medical College & Hospital Bangalore, India Dr. V. Seshiah Diabetes Care & Research Institute Chennai, India Mediciti Hospital Hyderabad, India Medwin Hospital Hyderabad, India Diabetes Thyroid Hormone Research Institute Pvt. Ltd. Indore, India Fortis Hospital Jaipur, India Bharti Research Institute of Diabetes & Endocrinology Karnal, India Amrita Institute of Medical Sciences Kochi, India Diabetes Action Centre Mumbai, India, 400067 BYL Nair Hospital Mumbai, India PD Hindhuja National Hospital Mumbai, India Gandhi Endocrinology & Diabetes Centre Nagpur, India All India Institute of Medical Sciences New Delhi, India Deenanath Mangeshkar Hospital & Research Centre Pune, India Diabetes Care & Research Centre Pune, India Health & Research Centre Trivendrum, India Christian Medical College Vellore, India Less <<
NCT00212290 Insulin Resistance ... More >> Type 2 Diabetes Mellitus Less << Phase 4 Completed - United States, Washington ... More >> VA Puget Sound Health Care System (Seattle Campus) Seattle, Washington, United States, 98108 VA Puget Sound Health Care System (American Lake Campus) Tacoma, Washington, United States, 98493 Less <<
NCT01028963 Type 2 Diabetes Mellitus Phase 2 Completed - Australia, Queensland ... More >> Auchenflower, Queensland, Australia Kippa-Ring, Queensland, Australia Czech Republic Beroun, Czech Republic Hlucin, Czech Republic Neratovice, Czech Republic Novy Jicin, Czech Republic Ostrava, Czech Republic Pardubice, Czech Republic Prague, Czech Republic Prelouc, Czech Republic Slany, Czech Republic Uhersky Brod, Czech Republic Unicov, Czech Republic Usti nad Labem, Czech Republic Germany Basenheim, Germany Berlin, Germany Cologne, Germany Dresden, Germany Heidelberg, Germany Mannheim, Germany Nuremberg, Germany Saarlouis, Germany Hungary Balatonfuered, Hungary Budapest, Hungary Satoraljaujhely, Hungary Szikszo, Hungary New Zealand Christchurch, New Zealand Wellington, New Zealand Less <<
NCT01175824 Diabetes Mellitus, Type 2 Phase 4 Completed - Argentina ... More >> For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Mar Del Plata, Argentina, B7600FZN For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Ramos Mejia, Argentina, B1704ETD Brazil For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Porto Alegre, Brazil, 90035-170 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. S?o Paulo, Brazil, 01244-030 China For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Changzhou, China, 213003 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Harbin, China, 150086 Egypt For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Alexandria, Egypt For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Cairo, Egypt, 11562 India For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Jaipur, India, 302018 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Vishakhapatnam, India, 530002 Korea, Republic of For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Daegu, Korea, Republic of, 700-712 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Goyang-Si, Korea, Republic of, 410-719 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Kyunggi-Do, Korea, Republic of, 425-020 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Seoul, Korea, Republic of, 134-090 Spain For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Málaga, Spain, 29010 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. San Boi De Llobregat, Spain, 08830 Turkey For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Antalya, Turkey, 07070 For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Istanbul, Turkey, 34865 Less <<
NCT01175824 - Completed - -
NCT00388518 Diabetes Mellitus Type 2 Phase 2 Completed - -
NCT00315146 Obesity Overw... More >>eight With Indications for Weight Loss Less << Phase 4 Completed - United States, North Carolina ... More >> Sticht Center on Aging, Wake Forest University Baptist Medical Center Winston-Salem, North Carolina, United States, 27157 Less <<
NCT00315146 - Completed - -
NCT03109288 Multiple Sclerosis Phase 1 Phase 2 Recruiting June 1, 2030 United States, Maryland ... More >> National Institutes of Health Clinical Center Recruiting Bethesda, Maryland, United States, 20892 Contact: For more information at the NIH Clinical Center contact Office of Patient Recruitment (OPR) ?? 800-411-1222 ext TTY8664111010 ?? prpl@cc.nih.gov Less <<
NCT02236962 Type 2 Diabetes ... More >> Obesity Cardiovascular Disease Less << Not Applicable Unknown - Australia, Victoria ... More >> Alfred Hospital Recruiting Melbourne, Victoria, Australia, 3004 Contact: Melissa F Formosa, B Sci ?? +61 9076 6518 ?? m.formosa@alfred.org.au ?? Principal Investigator: Bronwyn A Kingwell, PhD Less <<
NCT02473627 Healthy Phase 1 Completed - United Kingdom ... More >> London, United Kingdom, NW10 7EW Less <<
NCT00203996 Polycystic Ovary Syndrome ... More >> Obstructive Sleep Apnea Less << Phase 4 Terminated(Did not meet target... More >> patient accrual goals) Less << - United States, Illinois ... More >> University of Chicago Chicago, Illinois, United States, 60637 Less <<
NCT01217073 - Completed - -
NCT02917629 Oral Cavity Neoplasm ... More >> Oropharyngeal Neoplasm Stage 0 Oral Cavity Squamous Cell Carcinoma AJCC v6 and v7 Stage 0 Oropharyngeal Squamous Cell Carcinoma AJCC v6 and v7 Stage I Oral Cavity Squamous Cell Carcinoma AJCC v6 and v7 Stage I Oropharyngeal Squamous Cell Carcinoma AJCC v6 and v7 Stage II Oral Cavity Squamous Cell Carcinoma AJCC v6 and v7 Stage II Oropharyngeal Squamous Cell Carcinoma AJCC v6 and v7 Stage III Oral Cavity Squamous Cell Carcinoma AJCC v6 and v7 Stage III Oropharyngeal Squamous Cell Carcinoma AJCC v7 Stage IVA Oral Cavity Squamous Cell Carcinoma AJCC v6 and v7 Stage IVA Oropharyngeal Squamous Cell Carcinoma AJCC v7 Stage IVB Oral Cavity Squamous Cell Carcinoma AJCC v6 and v7 Stage IVB Oropharyngeal Squamous Cell Carcinoma AJCC v7 Less << Phase 2 Recruiting March 31, 2019 United States, Maryland ... More >> Johns Hopkins University/Sidney Kimmel Cancer Center Recruiting Baltimore, Maryland, United States, 21287 Contact: Wayne M. Koch ?? 410-995-4906 ?? wkoch@jhmi.edu ?? Principal Investigator: Wayne M. Koch ?? ?? ?? United States, Minnesota University of Minnesota/Masonic Cancer Center Recruiting Minneapolis, Minnesota, United States, 55455 Contact: Frank G. Ondrey ?? 612-625-3200 ?? ondre002@umn.edu ?? Principal Investigator: Frank G. Ondrey ?? ?? ?? United States, New York University of Rochester Recruiting Rochester, New York, United States, 14642 Contact: Shawn D. Newlands ?? 585-273-1943 ?? Shawn_Newlands@URMC.Rochester.edu ?? Principal Investigator: Shawn D. Newlands ?? ?? ?? United States, Wisconsin University of Wisconsin Hospital and Clinics Recruiting Madison, Wisconsin, United States, 53792 Contact: Aaron M. Wieland ?? 608-265-8207 ?? wieland@surgery.wisc.edu ?? Principal Investigator: Aaron M. Wieland Less <<
NCT02958995 - Completed - -
NCT00203996 - Terminated(Did not meet target... More >> patient accrual goals) Less << - -
NCT00879970 Diabetes Mellitus, Type 2 Phase 4 Terminated(FDA has placed the ... More >>trial on full clinical hold.) Less << - -
NCT00760578 Type 2 Diabetes Mellitus Phase 2 Completed - United States, California ... More >> Los Angeles, California, United States United States, Florida Miami Gardens, Florida, United States West Palm Beach, Florida, United States United States, Michigan Kalamazoo, Michigan, United States United States, South Carolina Greenville, South Carolina, United States United States, Texas Dallas, Texas, United States San Antonio, Texas, United States United States, Washington Renton, Washington, United States Less <<
NCT00760578 - Completed - -
NCT00086515 Diabetes Mellitus, Type II Phase 3 Completed - -
NCT00086515 - Completed - -
NCT01280695 Diabetes Mellitus, Type 2 Phase 2 Completed - United States, Arizona ... More >> Goodyear, Arizona, United States United States, California Chula Vista, California, United States Los Angeles, California, United States United States, Florida Bradenton, Florida, United States Hialeah, Florida, United States Pembroke Pines, Florida, United States United States, Illinois Chicago, Illinois, United States United States, Montana Butte, Montana, United States United States, North Carolina Greensboro, North Carolina, United States United States, Ohio Cincinnati, Ohio, United States United States, South Carolina Charleston, South Carolina, United States United States, Texas Austin, Texas, United States San Antonio, Texas, United States United States, Utah Salt Lake City, Utah, United States Less <<
NCT00879970 - Terminated(FDA has placed the ... More >>trial on full clinical hold.) Less << - -
NCT02958995 - Completed - -
NCT01280695 - Completed - -
NCT00571519 Type 2 Diabetes Mellitus Phase 3 Terminated(DSPD focussing on S... More >>tudy 301 to confirm clinical profile before proceeding.) Less << - United States, Alabama ... More >> Huntsville, Alabama, United States, 35801 Huntsville, Alabama, United States, 35802 United States, California San Diego, California, United States, 92128 San Francisco, California, United States, 94115 United States, Connecticut Ridgefield, Connecticut, United States, 06877 United States, Florida Fort Lauderdale, Florida, United States, 33308 Pembroke Pines, Florida, United States, 33026 United States, Mississippi Port Gibson, Mississippi, United States, 39150 United States, Nevada Las Vegas, Nevada, United States, 89119 United States, New Mexico Albuquerque, New Mexico, United States, 87109 United States, Ohio Kettering, Ohio, United States, 45429 United States, Pennsylvania Fleetwood, Pennsylvania, United States, 19522 Harrisburg, Pennsylvania, United States, 17112 United States, South Carolina Simpsonville, South Carolina, United States, 29681 United States, Texas Daingerfield, Texas, United States, 75638 Dallas, Texas, United States, 75216 Plano, Texas, United States, 75093 San Antonio, Texas, United States, 78205 Less <<
NCT00467285 - Completed - -
NCT00467285 - Completed - -
NCT02969798 Diabetes Mellitus, Type 2 ... More >> Impaired Glucose Tolerance (IGT) Impaired Fasting Glucose (IFG) Less << Not Applicable Recruiting July 2020 United States, Texas ... More >> The University of Texas Health Science Center at San Antonio Recruiting San Antonio, Texas, United States, 78229 Contact: Ralph A DeFronzo, MD ?? 210-567-6691 ?? defronzo@uthscsa.edu ?? Contact: Monica Palomo, BS ?? 210-567-6710 ?? palomom@uthscsa.edu ?? Principal Investigator: Ralph A DeFronzo, MD ?? ?? ?? Sub-Investigator: Eugenio Cersosimo, MD Less <<
NCT00063622 - Completed - -
NCT00485056 Diabetes PHASE4 COMPLETED 2025-04-10 International Centre for Circu... More >>latory Health, London, W2 1PG, United Kingdom Less <<
NCT00749047 Diabetes Mellitus, Type 2 PHASE4 UNKNOWN 2025-03-10 Christchurch Hospital, Christc... More >>hurch, Canterbury, 8001, New Zealand Less <<
NCT03864523 Adrenomyeloneuropathy|X-linked... More >> Adrenoleukodystrophy Less << PHASE2 COMPLETED 2025-07-19 Bellvitge University Hospital,... More >> L'Hospitalet de Llobregat, Barcelona, 08908, Spain|Donostia University Hospital, Donostia, 20080, Spain Less <<
NCT00816218 Type 2 Diabetes Mellitus PHASE4 COMPLETED 2025-11-08 The University of Texas Health... More >> Science Center at San Antonio, San Antonio, Texas, 78229, United States Less <<
NCT00402012 Diabetes Mellitus, Type 2 PHASE4 COMPLETED 2025-12-07 Pennington Biomedical Research... More >> Center, Baton Rouge, Louisiana, 70808, United States Less <<
NCT04473274 Coronavirus Infection|Diabetes PHASE4 COMPLETED 2020-12-01 Good Samaritan Hospital Corval... More >>lis, Corvallis, Oregon, 97330, United States Less <<
NCT00598013 Kidney Transplantation|Insulin... More >> Resistance|Atherosclerosis Less << COMPLETED 2025-11-07 Yonsei University College of M... More >>edicine, Seoul, 120-752, Korea, Republic of Less <<
NCT00441272 HIV Infections|Hepatic Steatos... More >>is|Insulin Resistance Less << PHASE2 COMPLETED - National Institutes of Health ... More >>Clinical Center, 9000 Rockville Pike, Bethesda, Maryland, 20892, United States Less <<
NCT00991055 Type 2 Diabetes PHASE4 UNKNOWN 2025-10-10 National Cheng Kung University... More >> Hospital, Tainan, Taiwan Less <<
NCT05753657 Metastatic Breast Cancer|Hyper... More >>insulinism|Hyperglycemia Drug Induced Less << EARLY_PHASE1 RECRUITING 2027-12-31 Rambam Health Care Campus, Hai... More >>fa, 3109601, Israel Less <<

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

2.81mL

0.56mL

0.28mL

14.03mL

2.81mL

1.40mL

28.06mL

5.61mL

2.81mL

References

 

Historical Records

Categories